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MOTOR CONTROL IN INDIVIDUALS WITH MULTIPLE SCLEROSIS
David J. Arpin, Ph.D.
University of Nebraska, 2016
Supervisor: Max J. Kurz, Ph.D.
This dissertation explored motor control in individuals with multiple sclerosis (MS) by
quantifying the behavioral and neurophysiological deficits present in these individuals.
We behaviorally quantified the precision of the ankle plantarflexor musculature of
individuals with MS. Our results indicated that the individuals with MS had a greater
amount of variability in the precision of the isometric ankle torques, and that this greater
variability was related to decreased walking performance. To further explore whether
these motor control deficits were due to aberrant cortical activity associated with
planning motor actions, we used magnetoencephalography to assess the motor planning
and execution stages of movement during a goal directed target matching task
performed with the knee joint. Interestingly, we found no differences between groups in
the cortical activity during the planning and execution stages of movement. However, we
did find that individuals with MS had a weaker post-movement beta rebound in the
precentral and postcentral gyri relative to healthy controls. These results suggest that
the internal model is faulty in individuals with MS. We further explored if the faulty
internal model could be due to sensory processing deficits by examining somatosensory
gating in these individuals using paired-pulse tibial nerve stimulation. Our results showed
reduced somatosensory gating for the individuals with MS, suggesting the inhibitory
intracortical circuits may be altered in these individuals. Finally, we examined the cortical
responses to single-pulse tibial nerve stimulation at rest and during movement, in order
to assess the performance of the sensory system during active movement. Our results
indicated that the individuals with MS were unable to properly suppress the
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somatosensory responses during movement. All together, the results of this dissertation
provide evidence that the impaired motor control of individuals with MS may be due to a
faulty internal model, which has become corrupt due to demyelination, and cannot be
properly updated due to impaired sensory processing.
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INTRODUCTION
Multiple Sclerosis
Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central
nervous system (CNS) that results in demyelination of the axons in the brain and spinal
cord. This demyelination reduces nerve conduction velocity, impairing the function of the
CNS (White & Dressendorfer, 2004). MS has been estimated to affect approximately
570,000 people in the United States (Campbell et al., 2014), and is estimated to cost
about $47,000 per patient per year (Kobelt et al., 2006). The majority of MS diagnoses
occur between the ages of 20 and 50 years, with women being about 3 times more likely
to be affected than men (Campbell et al., 2014). The exact cause of MS remains
unknown, however, it is believed that the disease results from a combination of genetic
and environmental factors (Compston & Coles, 2008; Milo & Kahana, 2010).
About 85% of individuals with MS initially present with a relapsing-remitting
(RRMS) course, characterized by a sudden appearance of symptoms followed by
subsequent improvement (Noseworthy et al., 2000; Keegan & Noseworthy, 2002).
Individuals with RRMS typically display a slow deterioration over many years regardless
of an acute attack, or relapse. This process typically occurs many years after onset and
is termed secondary progressive MS (Keegan & Noseworthy, 2002). Alternatively, MS
can present with a primary progressive (PPMS) course, which is characterized by a
gradual worsening of symptoms (Noseworthy et al., 2000; Keegan & Noseworthy, 2002).
A number of impairments are commonly associated with MS, including sensory
disturbances, gait and balance disorders, cognitive dysfunction, muscle weakness,
spasticity, ataxia, fatigue, hypersensitivity to temperature, bladder dysfunction, and
visual disturbances. These impairments result from reduced nerve conduction velocity
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due the demyelination in the brain and spinal cord (White & Dressendorfer, 2004). While
these symptoms vary widely between individuals, approximately 50% of individuals with
MS will require the use of a walking aid within 15 years of onset of the disease (Tremlett
et al., 2006). Furthermore, approximately 70% of individuals with MS report gait
dysfunction to be the most challenging aspect of the disease (LaRocca, 2011).
Historically, the clinical impression was that these mobility impairments were due
to weaker muscles that fatigue at a faster rate (Armstrong et al., 1983; Chen et al., 1987;
Ponichtera et al., 1992; Rice et al., 1992; Kent-Braun et al., 1997; Lambert et al., 2001).
Although this is a likely factor, there has been limited attention to how MS impacts motor
control. However, motor control problems that impact the precision of the motor output
have been reported in individuals with MS as well (Chen et al., 1987). Although these
problems have received limited attention, they may contribute to the larger gait and
balance problems reported with MS. Furthermore, the exact cause of these motor
control problems is unknown.
Motor control problems can arise due to a break down in any of the processes
that occur during the formulation and execution of a motor command. Prior research has
established that an internal model of the motor system is used to formulate a motor plan
based on sensory feedback, and that this plan is transformed into a motor command
(Figure 1; Kurz et al., 2014). Based on this model, dysfunction of any of these stages
(i.e., formulation of the motor plan based on the internal model, execution of the motor
plan through a sensorimotor transformation, sensory feedback) could lead to the motor
control impairments displayed by individuals with MS. Furthermore, it is well known that
MS results in alterations to the brain structure, due to tissue damage, as well as
functional changes in brain activity, which likely contributes to the impaired motor
control.
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Neuroimaging in Multiple
Sclerosis
Magnetic

resonance

imaging (MRI) is the most common
brain

imaging

diagnosing

and

technique

for

monitoring

the

progression of MS, however, there
is only a moderate relationship
between these structural images
and the clinical symptoms (Filippi &
Rocca, 2011). This disconnect is
likely due to the plasticity and
functional
brain,

reorganization

which

allows

of

the

individuals,

even in advanced stages of the
disease, to retain sensory, motor,
and cognitive function (Tomassini

Figure 1: Model for Completing Goal Directed
Movements. Conceptual scientific model of the
sensorimotor
transformation,
execution,
and
sensory feedback stages that are involved in
completing a goal directed motor task. These
stages are based on an internal model that is used
to predict the muscle activation patterns required to
match the desired motor outcome. Sensory
information is used during the formulation of the
motor plan and the online corrections in the evolving
motor pattern (Adapted from Kurz et al., 2014).

et al., 2012; Prosperini et al., 2015). Therefore, the use of functional brain imaging
techniques, such as functional MRI (fMRI), has grown in the past few decades. Several
of these studies have shown that individuals with MS have diffuse activation across the
cortical network compared to healthy adults when performing a simple motor task (Lee
et al., 2000; Rocca et al., 2002a; Filippi et al., 2004). Specifically, individuals with MS
showed increased activation of the primary sensorimotor cortex (SMC), supplementary
motor area (SMA), as well as secondary somatosensory cortex (SII), cingulate motor
area (CMA), intraparietal sulcus (IPS), and inferior parietal lobule, among others (Rocca
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et al., 2002a; Filippi et al., 2002, 2004). The results from these investigations suggests
that the diffuse activation may represent recruitment of other brain areas to overcome
the structural tissue damage in the primary cortical areas that would be involved in the
motor task. Alternatively, this diffuse activation my represent reduced deactivation of the
ipsilateral motor cortex, potentially contributing to the motor control problems seen in
these individuals (Manson et al., 2006; Manson et al., 2008). Nevertheless, these results
support the notion that the neurological damage incurred by MS may possibly be
overcome through the development of new and alternative pathways.
These prior functional neuroimaging studies have primarily focused on simple
hand movements, despite the importance of the lower extremity to maintaining a
functional gait pattern. However, several studies have assessed functional brain activity
in the motor network related to ankle movements (Rocca et al., 2002b; Ciccarelli et al.,
2006; Harirchian et al., 2010). These studies have shown increased activation of SII,
CMA, and precuneus cortex in individuals with MS during performance of ankle
movements (Ciccarelli et al., 2006; Harirchian et al., 2010). Additionally, individuals with
MS have shown greater activation of the superior temporal gyrus, rolandic operculum,
and putamen in response to passive movement of the ankle (Ciccarelli et al., 2006). This
increased activity during passive movements in regions associated with sensorimotor
integration suggests that impaired motor control may arise from deficits in sensory
processing. Sensory deficits could have a larger impact on the lower extremity than the
upper extremity due to the fact that the afferent and efferent information for the leg area
of the motor cortex is not as topographically distinct as it is for the upper extremity
(Machii et al., 1999).
In addition to widespread activation of the sensorimotor network, these studies
have suggested that the affected areas are important for motor planning and execution
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(Filippi et al., 2002, 2004). Therefore, altered activity within these areas further suggests
that the impaired motor control of individuals with MS may be due to deficits in motor
planning or execution. However, these speculations cannot be investigated with the
current fMRI techniques due to limitations in temporal resolution.
Neural Oscillatory Activity
Neural oscillatory activity in the sensorimotor cortices has been linked to the
processes

that

occur

during

the

planning

and

execution

of

movements.

Electroencephalography (EEG) and magnetoencephalography (MEG) are currently the
only brain imaging techniques with sufficient temporal resolution to assess these neural
oscillations. Numerous EEG and MEG experiments have shown that prior to the onset of
movement, the cortical oscillatory activity across the sensorimotor cortices decreases in
the beta frequency range (15-30 Hz) (Pfurtscheller & Berghold, 1989; Cassim et al.,
2000; Kaiser et al., 2001; Alegre et al., 2002; Kilner et al., 2005; Jurkiewicz et al., 2006;
Tzagarakis et al., 2010; Wilson et al., 2010, 2011). These results have been confirmed
by invasive methods such as subdural electrocorticography (ECoG) in epilepsy patients
(Crone et al., 1998; Pfurtscheller et al., 2003; Miller et al., 2007). This decrease in the
amount of power found in the beta band frequency, commonly termed beta
desynchronization, is thought to reflect task-related changes in the firing rate of local
populations of neurons, as they begin to prepare for the specific demands of the pending
movement. The consensus is that this beta event-related desynchronization (ERD) is
related to the formulation of the motor plan, because it occurs well before the onset of
movement, occurs sooner for easier motor tasks, and because the amount of reduction
is influenced by the certainty of the movement pattern to be performed (Figure 2A;
Kaiser et al., 2001; Alegre et al., 2003; Tzagarakis et al., 2010).
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Several invasive ECoG studies have also shown that the beta ERD is followed by
an increase (or synchronization) in the high gamma frequency range (>50 Hz) as the
motor plan is executed (Crone et al., 1998; Pfurtscheller et al., 2003; Miller et al., 2007).
This high frequency activity is restricted to a smaller population of neurons within the
primary motor cortex and appears to follow the homuncular organization common in
rolandic regions. However, very few EEG investigations have reported high gamma
band oscillatory activity during movement because the smaller number of active
neuronal generators creates a weaker signal that may be too attenuated by the skull
(Pfurtscheller et al., 2003). Furthermore, with EEG there is always a potential for the
higher frequencies to become contaminated because they occur at a similar frequency
as the head musculature. These measurement problems do not exist in MEG since this
technique measures the magnetic fields that naturally emanate from electrical activity in
active populations of neurons. The skull does not attenuate the strength or distort
magnetic fields, which makes the weaker high-frequency signals readily measurable.
Only within the last few years have MEG studies reported gamma-band neural
oscillatory activity during movement. The few studies that have been conducted have
shown that these gamma band oscillations are closely tied to the onset of muscular
activation, and are concentrated in the precentral gyrus (Figure 2B; Cheyne et al., 2008;
Wilson et al., 2010, 2011). Based on these initial findings, it has been proposed that the
rapid and temporally succinct gamma response initializes the activation of the motor
command, which is sent to the relevant motor units. While the central role of beta and
gamma neural oscillatory activity during movement is well appreciated, there has been
limited effort to use this knowledge to more precisely characterize the motor deficits
seen in individuals with MS.
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Figure 2: Exemplary Time-Frequency Plots. Exemplary time-frequency plots for a MEG
sensor that over the motor region of the cortex. A) Beta ERD (dark blue) occurs before
movement onset and represents the cortical activity during the motor planning stage, B)
Gamma ERS (red) is tied to movement onset and represents the cortical activity that occurs
at the execution of the motor plan.

One study has investigated differences in the latency of mu (8-13 Hz) ERD onset
in a group of individuals with MS and healthy controls (Leocani et al., 2005). The results
showed no significant difference in the latency of mu ERD onset between the two
groups. However, when the MS group was subdivided into two groups based on the
amount of brain tissue damage, the group with greater tissue damage showed
significantly delayed mu ERD onset. This suggests that the disruption of cortico-cortical
and cortico-subcortical connections due to tissue damage incurred with MS is related to
motor planning deficits (Leocani et al., 2005). Furthermore, evidence suggests deficits
in motor planning may also be the origin of fatigue in individuals with MS.
Individuals with MS complaining of fatigue have demonstrated altered frontal and
basal ganglia metabolism, measured with positron emission tomography (Roelcke et al.,
1997), as well as increased reaction times despite no differences in afferent and efferent
conduction velocities between fatigued and rested states (Sandroni et al., 1992). The
relationship between fatigue and mu and beta ERD, as well as beta event-related
synchronization (ERS), has been explored to assess the link between motor planning
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and fatigue (Leocani et al., 2001). Increased beta ERD was found in fatigued individuals
with MS compared to nonfatigued individuals with MS and controls. Additionally,
postmovement beta ERS was lower in fatigued individuals with MS compared to
nonfatigued individuals with MS and controls. Together these results further suggest that
motor planning deficits may be related to the fatigue experienced by these individuals.
Further exploration of these cortical oscillations will illuminate whether individuals with
MS have motor planning deficits, or whether their poor control resides in aberrant
sensory feedback or the actual execution of the motor command, or whether all of these
alternatives play a significant role.
Current Study
The current study aims to assess the behavioral and neurophysiological deficits
present in individuals with MS in order to explore the origin of these motor impairments.
To this end, this dissertation presents a series of studies that use a combination of
behavioral measures and high-density MEG recording to quantify the motor outcomes
and cortical activity of individuals with MS and a group of matched healthy controls. In
the first task, we will behaviorally quantify the control of the ankle joint musculature
during a steady-state isometric ankle plantarflexion task. In the second task, we will
assess the motor planning and execution stages of movement during a goal directed
target-matching task performed with the knee joint. In the third task, we will examine the
sensory gating response using a paired-pulse tibial nerve stimulation paradigm, which
assesses the integrity of the sensory system. Building on this, the fourth task will
examine how the sensorimotor cortex responds to single-pulse tibial nerve stimulation
during movement and at rest to indicate how the sensory system is performing during
movement, and how sensory feedback impacts motor control in individuals with MS.
Significant beta ERD and gamma ERS responses will be imaged using beamforming to
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examine differences between individuals with MS and healthy adults. We hypothesize
that the individuals with MS will have a greater amount of error in the steady-state
isometric ankle plantarflexion task, indicating motor control impairment. Furthermore, we
hypothesize that the beta ERD and gamma ERS will be reduced prior to and at
movement onset respectively in individuals with MS. Finally, we hypothesize that
individuals with MS will display altered sensorimotor cortical activity in response to tibial
nerve stimulation both at rest and during movement, and that this aberrant cortical
activity will be related to behavioral measures of motor control.
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CHAPTER 1:REVIEW OF LITERATURE
Epidemiology and Etiology
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous
system (CNS) that results in demyelination of the axons in the brain and spinal cord.
This demyelination reduces nerve conduction velocity, impairing the function of the CNS
(White & Dressendorfer, 2004). MS has been estimated to affect approximately 570,000
people in the United States (Campbell et al., 2014), and is estimated to cost about
$47,000 per patient per year (Kobelt et al., 2006). The majority of MS diagnoses occur
between the ages of 20 and 50 years, with women being about 3 times more likely to be
affected than men (Campbell et al., 2014).
The prevalence and incidence of MS varies worldwide, but is highest in northern
Europe, southern Australia, and the middle part of North America (Noseworthy et al.,
2000). The reason for this, and the exact cause of MS remains unknown, however, it is
believed that the disease results from a combination of genetic and environmental
factors (Compston & Coles, 2008; Milo & Kahana, 2010). Migration studies support the
existence of environmental factors by demonstrating that the geographical risk
associated with an individual’s birthplace is retained if migration occurs after the age of
15 years. However, if an individual migrates before 15 years of age, they assume the
risk of their new location (Hammond et al., 2000). Additionally, epidemics of MS have
been reported at specific geographic locations and time periods, supporting the idea that
exposure to an unidentified infectious agent may predispose individuals to later develop
MS (Kurtzke & Hyllested, 1987; Weinshenker, 1996).
The most widely accepted theory is that MS is an autoimmune disease induced
by a virus or infection. With this theory, the Epstein-Barr virus, the herpes virus and
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chlamydial pneumonia are currently believed to be the mostly likely causes (Herndon,
2003). Examination of the cerebrospinal fluid (CSF) indicates the presence of increased
immunoglobulin and oligoclonal bands in 65-95% of MS patients, supporting the theory
of an infection causing an autoimmune response, which results in pathological changes
(Chelmicka-Schoor & Arnason, 1994). Additionally, viral infections have been shown to
precede about 33% of relapses in MS (De Keyser et al., 1998).
Genetics also play a role in the acquisition of MS. Approximately 20% of patients
have a family history of MS. The risk is 3-5% for a fraternal twin, but increases to 26%
for an identical twin (Sadovnick & Ebers, 1995). Genetic studies have shown multiple
genetic markers linked to MS. Specifically, major histocompatibility complex proteins,
encoded on chromosome 6, have been linked to antibody production and MS. Evidence
suggests that although the disease is not inherited, individuals may inherit a genetic
susceptibility to immune system dysfunction (Kahana et al., 1994).
Pathophysiology
MS results in the formation of sclerotic plaque in the nervous system, for which
the disease is named. The formation of these plaques involves a number of processes
including inflammation, demyelination and remyelination, oligodendrocyte depletion and
astrocytosis, and neuronal and axon degeneration (Compston & Coles, 2008). The exact
order and the extent to which each of these processes takes place remains unknown.
However, it is known that an immune response triggers the production of T-lymphocytes,
macrophages, and immunoglobulins. In turn, these cells cross the blood-brain barrier
entering the CNS and attack the myelin sheath, which surrounds the nerves. This starts
inflammatory processes that signal the release of cytokines and antibodies, causing
further breakdown of the blood-brain barrier. Subsequent swelling occurs, along with
activation of macrophages, as well as further activation of cytokines and other
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destructive proteins (Compston & Coles, 2002). Disruption of the myelin sheath results
in demyelination, which slows neural transmission. With severe disruption of the myelin,
conduction block occurs, resulting in impaired function. Additionally, local inflammation
and infiltrates surround the acute lesion causing abnormally high pressure, which further
interferes with the conductivity of the nerve fibers. This inflammation gradually subsides,
which may partially account for the fluctuations in function that characterize the disease
(Compston & Coles, 2002).
During the early stages of MS the oligodendrocytes can partially repair the myelin
through remyelination. However, this remyelination is often incomplete and eventually
ceases as the disease progresses and the oligodendrocytes become involved (Chari,
2007). Demyelinated areas eventually are filled with astrocytes, and undergo gliosis,
resulting in glial scars, or plaques. At this stage the axon itself is interrupted and
undergoes retrograde degeneration. Axonal loss can vary from 10-20% in mild forms of
MS, to as much as 80% in more severe forms of the disease (Mews et al, 1998). Axonal
damage may have a non-immunological cause, resulting from excitotoxicity due to a
compensatory overexpression of sodium and calcium channels, which results from
decreased conductivity due to demyelination (Smith, 2007; Patejdl et al., 2016).
Additionally, oxidative stress and mitochondrial dysfunction, as well as direct damage
from T-lymphocytes may contribute to axonal damage (Patejdl et al., 2016).
Both acute and chronic lesions of varying size can occur anywhere in white or
gray matter. These lesions primarily affect white matter in early stages of the disease,
with lesions of gray matter evident in more advanced stages. Additionally, other
neurodegenerative processes involving the entire CNS take place. These processes
include changes in gray matter in the cortex, basal ganglia, brainstem, and spinal cord
(Costello, 2008). Brain atrophy also begins in early stages of the disease, and is

13
believed to be related to disability and progression of the disease (De Stefano et al.,
2014). There is also damage or direct dysfunction of oligodendrocytes that produce the
myelin (Chari, 2007; Costello, 2008).
Clinical Course
MS is highly variable and unpredictable between patients as well as within a
given individual over time. About 85% of individuals with MS initially present with a
relapsing-remitting (RRMS) course, characterized by a sudden appearance of symptoms
followed by subsequent improvement (Noseworthy et al., 2000; Keegan & Noseworthy,
2002). Individuals with RRMS typically display a slow deterioration over many years
regardless of an acute attack, or relapse. This process typically occurs many years after
onset and is termed secondary progressive MS (SPMS) (Keegan & Noseworthy, 2002).
Alternatively, MS can present with a primary progressive (PPMS) course, which is
characterized by a gradual worsening of symptoms (Noseworthy et al., 2000; Keegan &
Noseworthy, 2002). Although rare, MS can also present in a benign form, in which the
individual remains fully functional, or in a malignant form, which is characterized by rapid
onset and progression, leading to significant disability or death within a short time frame.
Permanent neurological disability can result from relapse with incomplete remission,
progression of the disease, or a combination of the two (Lublin & Reingold, 1996).
Clinical Manifestations
A number of impairments are commonly associated with MS, including sensory
disturbances, gait and balance disorders, cognitive dysfunction, muscle weakness,
spasticity, ataxia, fatigue, hypersensitivity to temperature, bladder dysfunction, and
visual disturbances. These impairments can result from reduced nerve conduction
velocity due the demyelination in the brain and spinal cord (White & Dressendorfer,
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2004). While these symptoms vary widely between individuals, and are often not
disease-specific, Lhermitte’s symptom and Uhthoff’s symptom are characteristic of
multiple sclerosis. Lhermitte’s symptom is the sensation of an electric shock running
down the spine and into the lower extremities, whereas Uhthoff’s symptom is a
temporary worsening of symptoms when the individual’s body temperature increases
(Compston & Coles, 2008).
Gait and balance impairments are another notable symptoms of MS.
Approximately 50% of individuals with MS will require the use of a walking aid within 15
years of onset of the disease (Tremlett et al., 2006). Historically, the clinical impression
was that these mobility impairments were due to weaker muscles that fatigue at a faster
rate (Armstrong et al., 1983; Chen et al., 1987; Ponichtera et al., 1992; Rice et al., 1992;
Kent-Braun et al., 1997; Lambert et al., 2001). Additionally, studies have reported a
higher proportion of type II muscle fibers due to disuse atrophy (Kent-Braun et al., 1997).
Although these are likely factors contributing to the motor impairments seen in these
individuals, there has been limited attention to how MS impacts motor control.
Studies have reported reduced firing rates of the motor units and/or an inability to
fully activate the available motor units in individuals with MS (Dorfman et al., 1989; Rice
et al., 1992). Additionally, motor control problems that impact the precision of the motor
output have been reported in individuals with MS as well (Chen et al., 1987). Although
motor control problems have received limited attention, evidence suggests that they
contribute to the larger gait and balance problems reported with MS (Davies et al.,
2015). Unfortunately, the exact cause of these motor control problems remains
unknown.
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Neuroimaging in Multiple Sclerosis
Structural neuroimaging
Magnetic resonance imaging (MRI) is the most common brain imaging technique
for diagnosing and monitoring the progression of MS. T2-weighted MRIs are commonly
used to measure total lesion volume. In individuals with RRMS and SPMS, total lesion
volume increases by about 5-10% per year (Paty et al., 1994). However, the strength of
the correlation between T2-hyperintense lesion burden and disability is rather low (Filippi
& Rocca, 2007). This disconnect is likely due to the limitations of the clinical scales used
to measure impairment and disability in these individuals, as well as the inability of
conventional MRI to characterize and quantify the severity of MS (Bakshi et al. 2008).
Cortical lesions are typically difficult to detect on conventional MRIs because they
are relatively small, have poor contrast against the surrounding gray matter, and can be
obscured by partial volume effects from CSF (Filippi & Rocca, 2007, 2011). However,
double-inversion-recovery magnetic resonance sequences can suppress the signal from
the white matter and CSF to significantly improve the ability of MRI to depict cortical
lesions (Filippi & Rocca, 2011). Relationships between cortical lesion burden and
progression of disability have been found (Calabrese et al., 2009b; Calabrese et al.,
2010a), as well as between cortical lesion burden and severity of cognitive impairment
(Calabrese et al., 2009a; Roosendaal et al., 2009). However, it is important to note that
this MRI technique has a number of limitations, including a low signal-to-noise ratio
among others, thus the ability to detect cortical lesion in individuals with MS remains
problematic (Filippi & Rocca, 2011).
Imaging studies have also found that brain volume decreases by about 1% per
year in individuals with MS, measured using T1-weighted MRI sequences (Miller et al.,
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2002). These brain atrophy measures appear to be more pathologically specific than T2
lesion load measures, however, they are still only moderately correlated with disability
measures in individuals with RRMS and SPMS (Miller et al., 2002; Giorgio et al., 2008).
Atrophy of specific areas has been suggested to help explain specific disease-related
symptoms. For instance, atrophy of the hippocampus has been related to memory
deficits (Sicotte et al., 2008), while atrophy of the frontal and parietal lobes has been
related to fatigue (Sepulcre et al., 2009; Pellicano et al., 2010).
Functional Neuroimaging
Plasticity and functional reorganization of the brain, even in advanced stages of
the disease, likely allow individuals with MS to retain sensory, motor, and cognitive
function (Tomassini et al., 2012; Prosperini et al., 2015). This likely contributes to the
poor relationships reported between structural brain images and the clinical symptoms
(Filippi & Rocca, 2011). Therefore, the use of functional brain imaging techniques, such
as functional magnetic resonance imaging (fMRI), has grown in the past few decades.
Several fMRI studies have shown that individuals with MS have diffuse activation
across the cortical network compared to healthy adults when performing a simple motor
task (Lee et al., 2000; Rocca et al., 2002a; Filippi et al., 2004). Specifically, individuals
with MS showed increased activation of the primary sensorimotor cortex (SMC),
supplementary motor area (SMA), as well as secondary somatosensory cortex (SII),
cingulate motor area (CMA), intraparietal sulcus (IPS), and inferior parietal lobule,
among others (Rocca et al., 2002a; Filippi et al., 2002, 2004). The results from these
investigations suggests that the diffuse activation may represent recruitment of other
brain areas to overcome the structural tissue damage in the primary cortical areas that
would be involved in the motor task. Alternatively, this diffuse activation may represent
reduced deactivation of the ipsilateral motor cortex, potentially contributing to the motor
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control problems seen in these individuals (Manson et al., 2006; Manson et al., 2008).
Nevertheless, these results support the notion that the neurological damage incurred by
MS may possibly be overcome through the development of new and alternative
pathways.
The development of this cortical reorganization has been explored in a crosssectional study (Rocca et al., 2005). Early in the disease course increased recruitment is
seen in cortical areas devoted to the performance of a motor task, such as the SMC and
SMA. Subsequently, bilateral activation of these regions is evident. Finally, in later
stages of the disease, activation of additional brain areas, which are normally recruited
to perform novel or complex tasks in healthy individuals, is seen (Rocca et al., 2005).
Evidence also exists supporting the idea that the functional changes seen in
individuals with MS may be maladaptive. Several studies have found reduced activation
of the sensorimotor network and increased activation of higher order brain areas, such
as the superior temporal sulcus and the insula, when performing a motor task (Rocca et
al., 2002b, 2010). Potentially, this may suggest that at a given threshold the brain is
unable to continue to reorganize and compensate for the tissue damage.
These prior functional neuroimaging studies have primarily focused on simple
hand movements, despite the importance of the lower extremity to maintaining a
functional gait pattern and the known mobility impairments in individuals with MS.
However, several studies have assessed functional brain activity in the motor network
related to ankle movements (Rocca et al., 2002b; Ciccarelli et al., 2006; Harirchian et al.,
2010). These studies have shown increased activation of SII, CMA, and precuneus
cortex in individuals with MS during performance of ankle movements (Ciccarelli et al.,
2006; Harirchian et al., 2010). Additionally, individuals with MS have shown greater
activation of the superior temporal gyrus, rolandic operculum, and putamen in response
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to passive movement of the ankle (Ciccarelli et al., 2006). This increased activity during
passive movements in regions associated with sensorimotor integration suggests that
impaired motor control may arise from deficits in sensory processing. Sensory deficits
could have a larger impact on the lower extremity than the upper extremity due to the
fact that the afferent and efferent information for the leg area of the motor cortex is not
as topographically distinct as it is for the upper extremity (Machii et al., 1999).
In addition to widespread activation of the sensorimotor network, these studies
have suggested that the affected areas are important for motor planning and execution
(Filippi et al., 2002, 2004). Therefore, altered activity within these areas further suggests
that the impaired motor control of individuals with MS may be due to deficits in motor
planning or execution. However, these speculations cannot be investigated with the
current fMRI techniques due to limitations in temporal resolution.
Electroencephalography (EEG) and magnetoencephalography (MEG) are
currently the only brain imaging techniques with sufficient temporal resolution to assess
the neural processes that occur during the planning and execution of movements.
Numerous EEG and MEG experiments have shown that prior to the onset of movement,
the neural oscillatory activity within the sensorimotor cortices decreases in the beta
frequency range (15-30 Hz) (Jurkiewicz et al., 2006; Cheyne et al., 2006, 2008; Gaetz et
al., 2010; Muthukumaraswamy, 2010; Heinrichs-Graham et al., 2014; Kurz et al., 2014;
Wilson et al., 2014; Tzagarakis et al., 2015). This decrease in the amount of power
found in the beta band frequency, commonly termed beta desynchronization, is thought
to reflect task-related changes in the firing rate of local populations of neurons, as they
begin to prepare for the specific demands of the pending movement. This beta eventrelated desynchronization (ERD) is thought to be related to the formulation of the motor
plan. However, there has been limited effort to use this knowledge to more precisely
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characterize the motor deficits seen in individuals with MS.
One study has investigated differences in the latency of mu (8-13 Hz) ERD onset
in a group of individuals with MS and healthy controls (Leocani et al., 2005). The results
showed no significant difference in the latency of mu ERD onset between the two
groups. However, when the MS group was subdivided into two groups based on the
amount of brain tissue damage, the group with greater tissue damage showed
significantly delayed mu ERD onset. This suggests that the disruption of cortico-cortical
and cortico-subcortical connections due to tissue damage incurred with MS is related to
motor planning deficits (Leocani et al., 2005). Furthermore, evidence suggests deficits
in motor planning may also be the origin of fatigue in individuals with MS.
Individuals with MS complaining of fatigue have demonstrated altered frontal and
basal ganglia metabolism, measured with positron emission tomography (Roelcke et al.,
1997), as well as increased reaction times despite no differences in afferent and efferent
conduction velocities between fatigued and rested states (Sandroni et al., 1992). The
relationship between fatigue and mu and beta ERD, as well as beta event-related
synchronization (ERS), has been explored to assess the link between motor planning
and fatigue (Leocani et al., 2001). Increased beta ERD was found in fatigued individuals
with MS compared to nonfatigued individuals with MS and controls. Additionally,
postmovement beta ERS was lower in fatigued individuals with MS compared to
nonfatigued individuals with MS and controls. Together these results further suggest that
motor planning deficits may be related to the fatigue experienced by these individuals.
Fatigue
Up to 90% of individuals with MS are affected by fatigue, even in early stages of
the disease (Riccitelli et al., 2011). Furthermore, individuals with MS report fatigue as the
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symptom that interferes most with their daily activities (Kesselring & Beer, 2005).
Despite this, the few medications available for the treatment of MS fatigue have limited
efficacy and can present various side effects (Kesselring & Beer, 2005).
Fatigue comes on abruptly and resembles an overwhelming flu-like exhaustion.
The severity of disease does not appear to be related to fatigue severity, as individuals
with mild symptoms report disabling fatigue as often as more affected individuals (Fisk et
al., 1994). Fatigue has also been associated with a number of disease-related factors,
including sleep disorders, depression, anxiety, level of neurologic disability, and disease
course (Mills & Young, 2011). There are also psychosocial factors contributing to fatigue,
as individuals with a low sense of environment mastery, or sense of control, report
significantly greater fatigue (Schwartz et al., 1996). Together these factors make it
difficult to determine the underlying cause of fatigue in individuals with MS.
Numerous hypotheses have been proposed to explain the causes of fatigue,
however, the high variability and subjective nature of the symptoms makes it difficult to
determine the underlying cause. One hypothesis is that fatigue arises due to the chronic
inflammation associated with MS. However, studies assessing the relationship between
cytokines and other biomolecules that are released throughout the course of
inflammation and self-reported measures of fatigue do not support this idea (Patejdl et
al., 2016). Another hypothesis is that fatigue is related to the cortical reorganization and
plasticity that occurs in individuals with MS. In theory, the fastest and most direct
connections between cortical regions are lost, requiring in the integration of more cortical
areas as compensation in order to perform motor or cognitive tasks (Patejdl et al., 2016).
This process reduces the information processing capacity and increases metabolic
requirements, potentially resulting in fatigue (Reddy et al., 2000). Furthermore, this
hypothesis seems to be supported by neuroimaging studies that show widespread

21
activation of the sensorimotor network, including areas that are important for motor
planning and execution (Filippi et al., 2002, 2004).
It has also been hypothesized that MS related fatigue may occur due to altered
cortical excitability and neurotransmission. Transcranial magnetic stimulation (TMS) is
often used to assess neural excitability by noninvasively stimulating a specific area of
the brain. In doing so, the motor threshold, or the lowest TMS stimulation intensity
required to elicit a muscle response, can be used as in indication of the neural
excitability, number of corticomotor neurons and/or strength of corticospinal projection.
Similarly, the size of the motor evoked potential can also reflect neural excitability.
Finally, the central motor conduction time can also be determined by subtracting the
latency of the spinal motor neuron to the muscle from the latency of the cortex to the
muscle (Yusuf & Koski, 2013). Several studies have used these techniques, however,
they do not appear to be related to self-reported fatigue measure (Yusuf & Koski, 2013).
Several studies have also examined muscle fatigue by assessing decreases in
task performance or measuring the time until the subject can no longer successfully
complete the task. The outcomes of these studies, however, have been mixed. Some
studies have found that individuals with MS fatigue more quickly than healthy controls
and that the decreased time to fatigue is related to self-reported measures of fatigue
(Petajan & White, 2000; Liepert et al., 2005). However, others have found no differences
in the time to fatigue, contractile force, or speed of the task (Perretti et al., 2004;
Thickbroom et al., 2006, 2008). Potentially, the mixed outcomes of these studies may be
due to the intensity of the exercise being performed, as the tasks consisted of
submaximal contractions (Yusuf & Koski, 2013).
To assess neurophysiological changes accompanying muscular fatigue in
individuals with MS, central drive and motor force production have been examined
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during fatiguing motor tasks. Central drive to the muscle is measures as a proportion of
the total electrically stimulated twitch force that can be accounted for by central rather
than peripheral mechanisms (Yusuf & Koski, 2013). Studies in patients with RRMS or
groups of patients with different disease courses have found greater decline in central
drive during exercise in individuals with MS compared to healthy controls (Sheean et al.,
1997, 1998). Additionally, decline in central drive during exercise is related to a greater
decline in maximal voluntary contractile force in individuals with MS (Sheean et al.,
1997; Romani et al., 2004). Therefore, changes in central drive appear to be an
important component of fatigue in individuals with MS. However, central fatigability is not
likely to be the primary explanation for fatigue symptoms, because it is not related to
patient-reported measures of fatigue severity (Sheean et al., 1997; Romani et al., 2004).
Thus, the underlying causes of fatigue remain difficult to identify.
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CHAPTER 2: MULTIPLE SCLEROSIS INFLUENCES THE PRECISION OF THE
ANKLE PLANTARFLEXION MUSCULAR FORCE PRODUCTION a
Introduction
Multiple sclerosis (MS) is a demyelinating disease that occurs in young adults
and often affects the control of the leg musculature. Numerous individuals with MS
experience mobility and balance impairments that limit their activities of daily living (Ellis
& Motl, 2013). Historically, the clinical impression was that these impairments were due
to weaker muscles that fatigue at a faster rate (Armstrong et al., 1983; Chen et al., 1987;
Ponichtera et al., 1992; Rice et al., 1992; Kent-Braun et al., 1997; Lambert et al., 2001).
Although this is likely a factor, there has been limited attention to how MS impacts the
precision of the ankle musculature control. Precise control of the ankle joint is important
for correcting the postural sway, clearing the foot during the swing phase of gait and
push-off at terminal stance (Horak & Nashner, 1986; Winter, 1991). It has been shown
that individuals with MS with higher Kurtzke Expanded Disability Status Scores (EDSS)
tend to generate less power by the ankle joint during the stance phase of gait (Huisinga
et al., 2013). Additionally, spasticity in the gastrocnemius and soleus muscles has been
shown to impact the gait and balance in individuals with MS (Sosnoff et al., 2011). Taken
together, these results suggest that a reduction in control of the ankle joint musculature
may be a primary factor that leads to the mobility and balance impairments seen in
individuals with MS.
Variability or error is present in all voluntary contractions and impacts the
precision and control of the motor performance (Hamilton et al., 2004; Kouzaki &
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Shinohara, 2010; Kwon et al., 2012). Several investigations have shown that aging
results in greater variability in the steady-state isometric performance of the ankle joint,
and that these variations may be a result of the inability to properly activate the motor
unit pool that innervates the ankle musculature (Sosnoff et al., 2011; Kwon et al., 2012).
Despite this insight, limited efforts have been made to determine if MS further amplifies
the amount of variability that occurs while attempting to control the precision of the ankle
musculature. A previous study has shown that individuals with MS may have an
increased amount of variability in motor unit firing rate (Dorfman et al., 1989). Given that
the variability of the motor unit discharge rate is known to be associated with increased
force variability during isometric force tasks (Enoka et al., 2003), it is possible that
individuals with MS may display an increased variability while trying to control the
precision of the muscular force. Potentially, a greater amplification of the variability at the
ankle joint may be a key factor for the mobility impairments often reported in individuals
with MS.
The primary purpose of this study was to quantify the amount of variability or
error in the precision of the steady-state ankle plantarflexion isometric muscular forces
generated by individuals with MS. We hypothesized that 1) compared with controls,
individuals with MS will have an amplified amount of variability when they attempt to
precisely match a low level isometric target with their ankle plantarflexors. Secondarily,
we hypothesized that 2) individuals with MS will have weaker isometric ankle
plantarflexion muscular strength, 3) the spatiotemporal gait kinematics will be altered,
and 4) the spatiotemporal gait kinematics will be related to the amount of variability seen
in the precision of the ankle plantarflexor target matching task.
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Methods
Twenty-two adults (Age: 49.3 ± 8 years; Female = 14) with relapsing-remitting or
secondary progressive MS participated in the study. The subjects had an average EDSS
of 5.3 ± 1 (median = 5.75), which indicates that on average each subject could walk
independently for at least 100 meters with an assistive device (e.g., cane). Twenty
normal, healthy adults served as a control group (Age: 45.1 ± 14 years; Female = 16).
All testing was done at the University of Nebraska Medical Center. This study was
approved by the Institutional Review Board and was performed in accordance with the
ethical standards laid down in the 1964 Declaration of Helsinki. Additionally, all
participants provided informed consent prior to participation in the study.
The subjects performed the isometric ankle plantarflexion contractions seated in
an isokinetic dynamometer (Biodex Inc., Shirley, NY). The chair of the isokinetic
dynamometer had the backrest set at an angle of 90ᵒ, and the participant had their knee
fully extended with their ankle in a neutral position. A foot strap was used to secure their
foot to the metal footplate. The largest torque generated from two maximum isometric
contractions was used to establish the participant’s maximum voluntary torque (MVT)
and was normalized by body weight (kg) prior to comparison. For the experiment, the
participant performed two steady-state isometric contractions at 20% of their MVT. The
target and the torque exerted by the participant was displayed as a bar graph on a large
monitor that was positioned ~1 meter away from the subject at eye level. The participant
was instructed to produce and hold a plantarflexion force that matched the 20% MVT
target. The participant was given ample time to practice achieving the target torque
before the two actual trials were recorded. These two trials were then averaged together
for all data measures. The voltage output from the torque motor was read by custom
LabVIEW (National Instrument Inc., USA) software and sampled at 1 kHz by a 14-bit

26
National Instruments analogue-to-digital converter. The voltage output from the Biodex
dynamometer was converted to Nm and displayed in real-time to the participant. The
maximum on the vertical scale of the bar graph was twice the target value (Kouzaki &
Shinohara, 2010). Each steady-state contraction was performed for 30 seconds. The
coefficient of variation (CV = [Standard Deviation of Torque/Mean Torque] x 100) was
used to assess the amount of variability present in the middle 15 seconds of the steadystate torque. A greater CV value was an indication of a larger amount of error in the joint
steady-state torque control (Christou & Tracy, 2006).
Prior to the completion of the ankle plantarflexion task described above, the
participants walked across a digital mat (GaitRITE, Sparta, NJ) at their preferred and
fast-as-possible walking speeds. The mat quantified the participant’s spatiotemporal
kinematics and was used to calculate the walking velocity, step width, step length,
cadence. In addition, the standard deviation of the step length, and step width were used
to quantify the gait variability. Each participant completed two walking trials at the
respective speeds and the data from these two trials was averaged together.
Independent t-tests were used to examine the differences between the MS and
control groups for the maximum torque, CV and the spatiotemporal kinematics.
Spearman rho correlations were used to evaluate the relationship between the CV of the
steady-state torque and the spatiotemporal kinematics, as well as MVT and the
spatiotemporal kinematics. All statistical analyses were conducted using SPSS version
22 (IBM, Armonk, NY), with an alpha level of 0.05.
Results
A representative time series for an individual with MS and a control performing
the ankle plantarflexion motor task is shown in Figure 3. Qualitatively it is apparent that
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the individual with MS had greater variability when trying to control the precision of the
ankle joint plantarflexor musculature. This observation was confirmed by the CV for the
steady-state torques, where the CV was greater for the individuals with MS compared to
the controls (p = 0.03; Figure 4A). Hence, indicating that the participants with MS

Figure 3: Exemplary Ankle Torques. Exemplary ankle joint torques for an MS subject (Top
panel) and control subject (Bottom panel).

generated more errors when attempting to control the precision of their ankle
plantarflexor muscular force production. The maximum torque generated by the ankle
plantarflexors was also significantly lower for the individuals with MS compared with the
controls (p = 0.03; Figure 4B). This indicated that the individuals with MS also had
weaker isometric ankle plantarflexor strength compared to the controls.
The spatiotemporal gait kinematics were notably different between the two
groups for all variables. At preferred walking speeds, the individuals with MS had a
slower walking velocity (MS = 0.68 + 0.22 m/s, controls = 1.28 + 0.14 m/s; p < 0.01),
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wider step width (MS = 0.16 + 0.04 m, controls = 0.11 + 0.02 m; p < 0.01), shorter step
length (MS = 0.44 + 0.08 m, controls = 0.67 + 0.07 m; p < 0.01), and slower cadence
(MS = 92.2 + 21.4 steps/min, controls = 114.5 + 9.4 steps/min; p < 0.01). In addition, the
step lengths (MS = 3.39 + 1.81 cm, controls = 1.91 + 0.86 cm; p < 0.01), and step widths
(MS = 2.81 + 1.39 cm, controls = 1.74 + 0.92 cm; p = 0.02) were more variable in the MS
group.

Figure 4: Coefficient of Variation and Maximum Torque Results. A) The coefficient of
variation for the ankle palntarflexor steady-state isometric torques is increased in the MS
compared to the control group. B) The normalized maximum voluntary isometric torque for the
ankle plantarflexor muscles is reduced in the MS compared to the control group. Data is
presented as the mean + standard error of the mean. * p<0.05.

The same was true at fast-as-possible walking speeds, with individuals with MS
having a slower velocity (MS = 0.93 + 0.36 m, controls = 1.98 + 0.27 m; p < 0.01), wider
step width (MS = 0.14 + 0.04 m, controls = 0.10 + 0.03 m; p < 0.01), shorter step length
(MS = 0.51 + 0.12 m, controls = 0.80 + 0.09 m, p <0.01), slower cadence (MS = 109.8 +
28.7 steps/min, controls = 148.4 + 16.3 steps/min, p < 0.01). The step length (MS = 3.45
+ 1.97 cm, controls = 2.29 + 1.49 cm; p = 0.04), and step width (MS = 2.54 + 0.98 cm,
controls = 1.86 + 0.79 cm; p = 0.02) continued to be more variable for the MS group at
the fast-as-possible walking speed.
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There were moderate negative correlations between the CV of the steady-state
torque and the preferred walking velocity (r = -0.48, p < 0.01), step length (r = -0.46, p <
0.01), and cadence (r = -0.31, p = 0.04). We also found moderate negative correlations
between the CV of the steady-state torque and the fast-as-possible walking velocity (r = 0.52, p < 0.01), step length (-0.48, p < 0.01), and cadence (r = -0.45, p < 0.01).
Altogether these correlations imply that a reduce precision of the control of the ankle
plantarflexor musculature force production may be partially related to a slower walking
speed and altered spatiotemporal kinematics.
We also found weak but positive correlations between the MVT and the preferred
walking velocity (r = 0.35, p = 0.03) and step length (r = 0.37, p = 0.02). The same was
true for the fast-as-possible walking speed where there was a weak to moderate positive
correlations between the MVT and walking velocity (r = 0.52, p < 0.01), step length (r =
0.46, p < 0.01), and cadence (r = 0.37, p =0.02). This suggests that weakness in the
ankle plantarflexors may also be partially related to the slower walking speed and altered
spatiotemporal kinematics of individuals with MS.
Finally, there were weak but positive correlations between the CV of the steadystate torque and the variability of the step length (r = 0.36, p = 0.02) and step width (r =
0.34, p = 0.03) during preferred walking speeds, as well as the variability of the step
width (r = 0.43, p = 0.01) during fast-as-possible walking speeds. These correlations
imply that poor control of the ankle musculature may partly contribute to the increased
gait variability seen in individuals with MS.
Discussion
Our results show that individuals with MS have an amplified amount of variability
or errors when attempting to control the precision of the force production of the ankle
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plantarflexor musculature. Comparable results have been previously reported for
sustained short duration knee maximal isometric contractions for individuals with MS
(Horak & Nashner, 1986). Taken together, these results indicate that individuals with MS
have greater errors when attempting to control of the precision of the lower extremity
musculature. Prior electroencephalography (EEG) studies have eluded that the
neurologic injury caused by MS to the central nervous system may impact the cortical
activation that that is associated with planning motor actions (Leocani et al., 2001;
Leocani et al., 2005). Transcranial magnetic stimulation (TMS) studies have also shown
that the transmission of the motor command along the corticospinal tracts is delayed in
persons with MS (Gagliardo et al., 2007; Kale et al., 2009). Based on these
neurophysiological outcomes, it is likely that the heighten variability seen in the ankle
plantarflexion muscular performance reflects the extent of the damage within the
corticospinal fiber tracts and/or the sensorimotor cortices.
The MVT for the ankle plantarflexors was lower for the individuals with MS,
indicating that the participants with MS had strength deficits. This result concurs with
what has been well established in the literature (Armstrong et al., 1983; Chen et al.,
1987; Ponichtera et al., 1992; Rice et al., 1992; Kent-Braun et al., 1997; Lambert et al.,
2001; Wagner et al., 2014). Weaker muscles are known to have more noise in their
isometric force production (Hamilton et al., 2004); therefore, it is possible that the greater
amount of error seen in the precision of the ankle isometric force production of the
individuals with MS may partially be a result of the inability to suppress these stochastic
features. Potentially, demyelination may not only promote weakness, but also allows for
the biological noise to further infiltrate the intended motor output.
Our results also showed that individuals with MS had a slower walking velocity,
wider step width, shorter step length, and slower cadence at both preferred and fast-as-
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possible walking speeds. Prior studies have shown similar alterations to the
spatiotemporal gait kinematics of individuals with MS (Benedetti et al., 1999; Kelleher et
al., 2010). Additionally, we found negative correlations between the CV of the steadystate torque and velocity, step length, and cadence for both the preferred and fast-aspossible walking speeds. This suggests that a greater amount of variability or error in the
precision of the ankle plantarflexion force was related to a slower walking velocity, a
shorter step length and a slower cadence. Therefore, these results imply that the
mobility deficits seen in participants with MS may have been related to a reduction in the
control of the precision of the ankle musculature force production.
There were positive correlations between the strength of the ankle plantarflexors
and preferred walking velocity and step length. In addition, there were complementary
positive correlations between the strength of the ankle plantarflexors and the fast-aspossible walking velocity, step length and cadence. This suggests that weakness in the
ankle plantarflexors is likely also related to slower walking velocity and altered
spatiotemporal kinematics. Prior research has shown that resistance training protocols
targeting the lower extremities improves the strength of the ankle joint musculature, as
well as the gait kinematics of individuals with MS (White et al., 2004; Gutierrez et al.,
2005). Together these results imply that the mobility deficits seen in individuals with MS
may be partially related to strength deficits as well as deficits in the control of the ankle
musculature.
Our results also showed that individuals with MS had greater variability in the
step length and step width during both preferred and fast-as-possible walking speeds.
Increased gait variability is known to exist in individuals with MS; however the
mechanisms contributing to this variability remains poorly understood (Socie & Sosnoff,
2013; Kaipust et al., 2012; Socie et al., 2013, 2014). Likely there are combinations of
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possible factors that contribute to increased gait variability, as variability in the gait
pattern may arise from a breakdown in any of the numerous neural processes. Our
results suggest that poor control of the ankle musculature may be partially related to the
heighted gait variability seen in individuals with MS. However, we are somewhat
cautionary to state the that the gait variability is primarily due to poor control of the ankle
joint because the strength of our correlations were relatively weak, which suggests that
other factors likely play a more prominent role (i.e., spasticity, fatigue). Prior research
has shown that a large number of steps are necessary to accurately quantify gait
variability (Owings & Grabiner, 2003). Therefore, it is alternatively possible that the weak
correlations seen here may be due to the inability of a few steps to accurately capture
the gait variations seen in our participants.
Interventions aimed at improving the control of the ankle joint in individuals with
MS have been limited; however, the few studies that have been conducted have shown
improvements in ankle joint function following therapeutic intervention. Huisinga and
colleges have shown improvements in the dynamic joint torques produced by the ankle
during the stance phase of gait in individuals with MS following an elliptical exercise
intervention (Huisinga et al., 2012). Additionally, prior studies have shown improvements
in strength and alterations in the interference EMG after individuals with MS complete a
strength training program (Fimland et al., 2010; Dalgas et al., 2013). Taken together,
these studies suggest that therapeutic interventions can potentially improve the control
of the ankle muscular force production and strength of individuals with MS. Potentially,
such improvements may also reduce the amount of error in the precision of the muscular
force production of the ankle plantarflexors, which may lead to improvements in balance
and mobility.
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There are several limitations to this study. Although we have shown that
individuals with MS exhibit a greater amount of variability or errors in the precision of
their isometric plantarflexion forces at 20% MVT, it remains unknown how control of the
plantarflexor musculature changes with varying force levels or during a dynamic
isokinetic force matching tasks. The steady-state isometric target matching task used in
this study likely does not approximate the ankle control required during gait, which may
explain why the correlations we found between the CV and the spatiotemporal gait
kinematics were moderate. Additionally, it is possible that the greater variability seen in
the precision of the muscular force production of individuals with MS may have been
related to possible visuomotor impairments, as these are common in individuals with
MS. Thus, it is plausible that the larger variability in force production in individuals with
MS may be due to a need to see larger changes in the visual feedback in order to make
corrections. Finally, with this study we are unable to identify the specific underlying
neurophysiological mechanisms that may be responsible for the heightened variability in
the precision of the ankle plantarflexor musculature force production.
Conclusion
Our results show that individuals with MS have an amplified amount of variability
when attempting to control the precision of the force production of the ankle plantarflexor
musculature. These precision errors appear to be partially related to the extent of the
impairments seen in the walking speed, spatiotemporal kinematics and gait variability of
individuals with MS. These results further fuel the impression that a reduction in control
of the ankle joint musculature may be a key factor in the mobility and balance
impairments seen in individuals with MS.
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CHAPTER 3: ALTERED SENSORIMOTOR CORTICAL OSCILLATIONS IN
INDIVIDUALS WITH MULTIPLE SCLEROSIS SUGGESTS A FAULTY INTERNAL
MODEL
Introduction
Multiple sclerosis (MS) is a demyelinating disease that impacts the function of the
central nervous system, and often results in impaired muscular performance. Previously,
we have shown that individuals with MS have greater errors when attempting to control
the precision of the lower extremity force production (Davies et al., 2015; Arpin et al.,
2016). While these results are insightful, the neurophysiological abnormalities that may
be responsible for the reduced muscular force control remains unknown. Potentially, the
errors in the precision of the force production may partly be a result of imperfections in
the internal model that is used to make accurate predictions of the motor output that will
meet the task demands.
Prior research has established that the brain maintains and updates an internal
model that is used to predict the muscular synergies necessary to achieve a motor goal
(Kording et al., 2004; Shadmehr, 2004; Wolpert, 2007). This internal model is used to
formulate a motor plan based on sensory feedback and knowledge of results from prior
attempts to achieve the motor goal. The motor plan is then transformed into a motor
command, which contains the predicted muscular synergies required to achieve the
motor goal. Once the motor command is executed, the sensory feedback that occurs
can then be compared with the sensory feedback expected by the internal model. Any
mismatch between the actual and expected sensory feedback can be used to make
corrections to the movement trajectory (Kording et al., 2004; Shadmehr, 2004; Wolpert,
2007). A breakdown in any of these processes may contribute to the errors observed in
the precision of the force production of individuals with MS. However, determining where
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that breakdown may occur (i.e., motor planning, execution, or feedback stage) is
inherently difficult due to the speed at which each of these processes occurs.
Within the past few decades, advances in neuroimaging techniques have allowed
stage-like changes in neural oscillatory activity in the sensorimotor cortices to be
identified, and these stage-like changes appear to correspond to the processes that
occur during the planning and execution of movements. Electroencephalography (EEG)
and magnetoencephalography (MEG) are currently the only brain imaging techniques
with sufficient temporal resolution to assess these neural oscillations. Numerous EEG
and MEG experiments have shown that prior to the onset of movement, cortical
oscillatory activity across the sensorimotor cortices decreases in the beta frequency
range (15-30 Hz) (Jurkiewicz et al., 2006; Cheyne et al., 2006, 2008; Gaetz et al., 2010;
Muthukumaraswamy, 2010; Kurz et al., 2014; Wilson et al., 2014; Heinrichs-Graham &
Wilson, 2015; Tzagarakis et al., 2015; Heinrichs-Graham et al., 2014, 2016). This
decrease in the amount of power found in the beta band frequency, commonly termed
beta desynchronization, is thought to reflect task-related changes in the firing rate of
local populations of neurons, as they begin to prepare for the specific demands of the
pending movement. The consensus is that this beta event-related desynchronization
(ERD) is related to the formulation of the motor plan, because it occurs well before the
onset of movement, occurs sooner for easier motor tasks, and because the amplitude of
the response is influenced by the certainty of the movement pattern to be performed
(Kaiser et al., 2001; Alegre et al., 2003; Tzagarakis et al., 2010). Additionally, upon
completion of a movement, there is a robust beta frequency event-related
synchronization, which is referred to as the post-movement beta rebound (PMBR)
(Tzagarakis et al., 2010; Gaetz et al., 2010, 2011; Wilson et al., 2010, 2011).
Traditionally, this PMBR was believed to represent the active inhibition of neuronal
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networks after movement termination (Salmelin et al., 1995; Neuper & Pfurtscheller,
2001; Solis-Escalante et al., 2012) and/or afferent feedback to the motor cortices
(Cassim et al., 2001; Houdayer et al., 2006; Parkes et al., 2006). However, recent
experimental work has shown that changes in the PMBR may reflect the certainty of the
feedforward motor actions that were executed based on the internal model (Tan et al.,
2016).
While the central role of beta neural oscillatory activity in motor performance is
well appreciated, there has been limited effort to use this knowledge to more precisely
characterize the motor deficits seen in individuals with MS. Therefore, the purpose of
this study was 1) to determine if beta oscillatory activity is altered in individuals with MS
compared to healthy controls when completing a knee extension target matching task,
and 2) to identify if there is a relationship between beta oscillatory activity and the
precision of the knee joint muscular force production.
Methods
Subjects
Fifteen individuals with relapsing-remitting or secondary progressive MS (Age =
57.07 + 6.26 yrs.; Female = 11) and fifteen healthy age and sex matched individuals
(Age = 55.13 + 6.93; Female = 12) participated in this study. The individuals with MS
had an average Kurtzke Expanded Disability Status Scale of 5.5 + 0.7, which indicated
that on average they could walk independently for at least 100 m. At the time of data
collection, none of the patients had a relapse or a change in medication for at least 3
months. All testing was done at the University of Nebraska Medical Center. The
Institutional Review Board at the University of Nebraska Medical Center reviewed and
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approved the protocol for this investigation. Additionally, all participants provided
informed consent prior to participation in this study.
Experimental Paradigm
The participants were seated upright in a magnetically-silent chair. The
experimental paradigm consisted of an isometric knee extension target matching task.
The participants used their most affected leg (nondominant for the healthy comparison
group) to match target forces that varied randomly between 5-30% of the participant’s
maximum isometric knee extension force. The target force was visually displayed as a
box on a back-projection screen that was ~1 meter in front of the participant at eye level,
and the force generated by the participant was shown as a smaller box (beneath the
larger box) that moved vertically based on the isometric force generated (Figure 5A).
Each participant performed 120 target matching trials. Each trial lasted 5.0 s and was
followed by a 5.0 s rest period. A successful match occurred when the box representing
the participant’s isometric force was inside the target box for 0.3 s.
A custom-built magnetically-silent force transducer was used to measure the
isometric knee extension forces generated by the participants (Figure 5B). This device
consisted of a 20 x 10 cm airbladder that was inflated to 317 kPa, and fixed to the
anterior portion of the lower leg just proximal to the lateral malleoli. A thermoplastic shell
encased the outer portion of the airbladder and was secured to the chair with ridged
strappings. Changes in the pressure of the airbag as the participant generated an
isometric contraction were quantified by an air pressure sensor (Phidgets Inc., Calgary,
Alberta, CA), and were subsequently converted into units of force. The force data was
concurrently collected with the MEG data at 1 kHz. For each trial, the reaction time,
amount of overshoot, average velocity to the target, time to initially reach the target, and
the time to successfully match the target were computed offline. Separate t-tests at the
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0.05 alpha level were used to determine if there were differences in the behavioral
variables of the respective groups.

Figure 5: Depiction of Target Matching Task and Pneumatic Force Transducer.
A) Depiction of the target matching task. The isometric knee extension force generated by the
participant animates the yellow box to ascend vertically to match the green target box. Each
trial lasted 5.0 s and was followed by a 5.0 s rest period. B) Depiction of the custom-built
pneumatic force transducer that was positioned just proximal to the lateral malleoli of the
participant.

MEG Data Acquisition and Coregistration
All MEG recordings were conducted in a one-layer magnetically shielded room
with active shielding engaged for advanced environmental noise compensation. During
data acquisition, participants were monitored via real-time audio-video feeds from inside
the shielded room. Neuromagnetic responses were acquired with a bandwidth of 0.1 –
330 Hz and were sampled continuously at 1 kHz using an Elekta Neuromag system
(Helsinki, Finland) with 306 MEG sensors, including 204 planar gradiometers and 102
magnetometers. With the use of the MaxFilter software (Elekta), each MEG dataset was
individually corrected for head motion during task performance and subjected to noise
reduction using the signal space separation method with a temporal extension (Taulu &
Simola, 2006).
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Four coils were affixed to the head of each participant and were used for
continuous head localization during the MEG experiment. Before the experiment, the
location of these coils, three fiducial points, and the scalp surface were digitized to
determine their three-dimensional position (Fastrak 3SF0002, Polhemus Navigator
Sciences, Colchester, VT, USA). Once the participant was positioned for MEG
recording, an electric current with a unique frequency label (e.g., 322 Hz) was fed to
each of the four coils. This induced a measurable magnetic field and allowed each coil to
be localized in reference to the sensors throughout the recording session. Since the coil
locations were also known in head coordinates, all MEG measurements could be
transformed into a common coordinate system. With this coordinate system (including
the scalp surface points), each participant’s MEG data was coregistered with structural
T1-weighted MRI data using three external landmarks (i.e., fiducials) and the digitized
scalp surface points prior to source space analyses. Structural MRI data were aligned
parallel to the anterior and posterior commissures and transformed into the Talairach
coordinate system (Talairach & Tournoux, 1998) using the volumetric subspace warping
method implemented in BrainVoyager QX version 2.2 (Brain Innovations, The
Netherlands).
MEG Pre-Processing
Artifact rejection was based on a fixed threshold method, supplemented with
visual inspection. Two participants with MS and two controls were excluded from data
analysis due to excessive MEG artifacts. The data analysis epochs were a total duration
of 10.0 s (-3.0 to +7.0 s), with the onset of movement defined as time 0.0 s and the
baseline defined as -2.0 to -1.2 s. Artifact-free epochs for each sensor were transformed
into the time-frequency domain using complex demodulation (resolution: 2.0 Hz, 25 ms)
and averaged over the respective trials to generate plots of the mean spectral density.
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The data were then normalized by dividing the power value of each time-frequency bin
by the mean power during the baseline period (-2.0 to -1.2 s). This normalization
procedure allowed for the visual inspection of power changes that were present in
sensor space.
Sensor Level Statistics
We determined the precise time-frequency bins of interest by conducting
statistical analysis of the spectrograms corresponding to the gradiometers located near
the sensorimotor cortices. Each data point in the spectrogram was initially evaluated
using a mass univariate approach based on a general linear model. Briefly, we
conducted unpaired t-tests on each data point to identify group differences, and the
output spectrograms of t-values (one per sensor) were thresholded at p < 0.05. Next, the
time-frequency bins that survived this threshold were clustered with temporally and/or
spectrally neighboring bins that were also above the threshold, and a cluster value was
derived by summing all of the t-values of all data points in the cluster. Nonparametric
permutation testing was then used to derive a distribution of cluster values, and the
significance level of the clusters was tested directly using this distribution. For each
comparison, 10,000 permutations were computed to build a distribution of cluster values.
Based on this analysis, the time-frequency windows that were significantly different
between the two groups were identified for beamforming.
MEG Source Imaging & Virtual Sensor Extraction
A minimum variance vector beamforming algorithm was used to calculate the
source power across the entire brain volume (van Veen et al., 1997; Gross et al., 2001).
The single images were derived from the cross spectral densities of all combinations of
the 204 MEG gradiometers within the time-frequency ranges of interest, and the solution
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of the forward problem for each location on a grid specified by input voxel space.
Following convention, the source power in these images were normalized per participant
using a separately averaged pre-stimulus noise period of equal duration and bandwidth
(Hillebrand et al., 2005). Thus, the normalized power per voxel was computed for the
time-frequency ranges of interest over the entire brain volume per participant at 4.0 x 4.0
x 4.0 mm resolution. Each participant’s functional images were transformed into a
standardized space using the transform previously applied to the structural MRI volume
(Talairach & Tournoux 1998). The MEG pre-processing and imaging was performed
using the BESA software (BESA version 6.0), and MEG-MRI coregistration was
performed using the BrainVoyager QX (Version 2.2) software.
The individual beamformer images were averaged across all participants to
identify the peak responses. We then extracted virtual sensors corresponding to the
peak voxel of these responses. The virtual sensors were created by applying the sensor
weighting matrix derived through the forward computation to the preprocessed signal
vector, which resulted in a time series with the same temporal resolution as the original
MEG recording (Heinrichs-Graham & Wilson, 2016). Once the virtual sensors were
extracted, they were transformed into the time-frequency domain and the power, relative
to baseline, was averaged across the frequency window of interest per unit time for each
individual to derive the temporal evolution of the key oscillatory responses. Statistical
analysis of these voxel time series was then performed using nonparametric permutation
testing to determine differences between the two groups. Similar to our sensor space
analysis, a cluster alpha of 0.05 was used, and 10,000 permutations were computed.
Finally, we averaged the power across the time windows of interest for each individual to
derive the strength of the event-related neural activity (see below). Pearson product
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moment correlations were use to determine if there was a correlation between the
strength of the event-related neural activity and the respective behavioral variables.
Results
Behavioral Analysis
Significant differences were found between the two groups for all behavioral
measures (Figure 6). Individuals with MS had a longer reaction time (MS = 0.49 + 0.16
s, Controls = 0.36 + 0.06 s, p=0.01), greater amount of overshoot (MS = 7.43 + 2.69 %,

Figure 6: Target Matching Task Behavioral Results. Group averages (mean + SD) for
reaction time, amount of overshoot, average velocity to the target, time to initially reach the
target, and time to match the target. * p < 0.05.
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Controls = 4.58 + 1.59 %, p<0.01), slower average velocity to the target (MS = 40.0 +
19.7 m/s, Controls = 60.7 + 22.0 m/s, p=0.02), longer time to initially reach the target
(MS = 1.20 + 0.36 s, Controls = 0.91 + 0.23 s, p=0.02), and longer time to match the
target (MS = 2.72 + 0.47 s, Controls = 2.01 + 0.23 s, p<0.01). Altogether the results
indicate that the precision of the isometric knee force production was reduced for the
individuals with MS.
Sensor Level Analysis
Group averages of the
peak sensor, located near the
leg area of the sensorimotor
cortices, are shown in Figure
7.

Strong

pre-

and

peri-

movement beta (15-30 Hz)
activity can be seen in the
average data of both groups.
Additionally, a strong PMBR
can be seen in the healthy
individuals, but this response
appears to be absent in the
individuals with MS. Based on
our

statistical

analysis,

we

found no significant difference
between the two groups for
the

pre-

or

peri-movement

Figure 7: Averaged Time-Frequency Plots. Averaged
time-frequency plots for the control group (top) and group
with MS (bottom) using the sensor with the maximum
response located near the leg sensorimotor region (the
same sensor was used in all participants). The onset of
movement is defined as time 0.0 s and the baseline is
defined as -2.0 to -1.2 s. Strength of pre- and perimovement alpha and beta ERD (blue) appears similar in
the 8-32 Hz frequency range from approximately -0.3 to
1.8 s. The PMBR (red) in the 16-26 Hz frequency range
can also be seen from approximately 3.0 to 5.0 s in the
healthy control group, but this response was strongly
diminished in the group with MS.
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beta ERD (p > 0.05; corrected). However, a significant group difference (p = 0.048;
corrected) was found for the PMBR ranging from 16-26 Hz from approximately 2.0 to 5.2
s. To image this neural response, we focused on the time window corresponding to the
maximum PMBR (16-26 Hz; 4.0 to 4.8 s).
Beamformer and Peak Voxel Analysis
Beamformer images corresponding to the 4.0 to 4.8 s time window (16-26 Hz)
were computed in each participant and averaged across both groups. The resulting data
indicated that the PMBR originated near the leg area of the pre/postcentral gyri (Figure
8A). The peak voxel from this location was then extracted from this area and examined
statistically. As expected, there continued to be no significant differences in the beta
ERD between the two groups during the planning or execution period of the virtual
sensor time course (p > 0.05; corrected). However, the strength of the PMBR was
significantly weaker in the individuals with MS from 2.725 to 4.500 s (p = 0.006;
corrected) and 4.575 to 5.025 s (p = 0.047; corrected) as shown in Figure 8B.
We also found moderate negative correlations between the strength of the PMBR
and the time to successfully match the target (r = -0.66, p < 0.01), and reaction time (r =
-0.39, p = 0.05). These correlations suggest that a stronger PMBR is related to improved
performance on the target force matching task. No significant correlations were found
between the strength of the PMBR and the amount of overshoot, average velocity to the
target, or the time to initially reach the target (p’s > 0.05).
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Figure 8: Grand Average Beamformer Image and Average Peak Voxel Time Series.
A) Grand average of the beamformer images from all participants indicated that the postmovement beta rebound (PMBR; 16-26 Hz, 4.0 – 4.8 s) was generated by neural activity in
the leg area of the pre/postcentral gyri. B) Group averages of the time series of the beta
activity (16-26 Hz) extracted from the peak voxel. Time is shown on the x-axis, with movement
onset occurring at 0.0 s (dotted line), while relative power (expressed as a percentage from
baseline) is shown on the y-axis. The PMBR is stronger in healthy controls (blue line) than in
individuals with MS (orange line). The shaded area around each line denotes the standard
error of the mean (SEM).

Discussion
The purpose of this study was to evaluate neural oscillatory activity in the
sensorimotor cortices of individuals with MS and healthy individuals during a goaldirected knee extension task. Our primary finding was that individuals with MS exhibited
a weaker PMBR in the precentral and postcentral gyri relative to healthy individuals. Our
results also demonstrated that the precision of the isometric knee force production was
reduced in individuals with MS, and that the strength of the PMBR was correlated with
performance of the isometric knee force task.
Our MEG results showed no differences between individuals with MS and
healthy in the pre- and peri-movement beta ERD. This finding was contrary to our
prediction, as motor planning deficits have previously been reported in individuals with
MS (Ternes et al., 2014). Prior EEG work also found that the latency and amplitude of
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the beta ERD did not differ between healthy individuals and non-fatigued individuals with
MS (classified by the Fatigue Severity Scale) (Leocani et al., 2001). However, this study
did find increased beta ERD in fatigued individuals with MS compared to non-fatigued
individuals and healthy individuals (Leocani et al., 2001). This may suggest that fatigue
is related to motor planning deficits in individuals with MS. Given these somewhat
conflicting reports, additional studies are warranted to further characterize the motor
planning deficits seen in individuals with MS, and determine how they are associated
with reported fatigue symptoms.
In our study, individuals with MS exhibited a weaker PMBR in the pre- and postcentral gyri relative to healthy individuals. Similar findings were previously reported in an
EEG study of self-paced movements of the hand in individuals with MS (Leocani et al.,
2001). Together, these results provide mounting evidence that the PBMR response is
disturbed in individuals with MS. Recent work indicates that the amplitude of the PMBR
is related to the uncertainty in the feedforward estimations of the internal model (Tan et
al., 2016). Since a stronger PMBR appears to be related to improved certainty of the
internal model, we speculate that the internal model may be faulty in individuals with MS.
Prior work appears to agree with this hypothesis. Using a multisensory model of sensory
feedback control, Heenan et al. (2014) found that there appears to be a mismatch
between the predicted and actual arm dynamics exhibited by individuals with MS during
a reaching task. Furthermore, they suggest that the muscular control problems seen in
individuals with MS may be due to an inability to adapt the internal estimate of
movement duration to account for increases in the visual processing time. Taken
together, this suggests that the internal model may become corrupt overtime due to
demyelination in the cortical and spinal tracts that are necessary for relaying sensory
feedback and properly updating the internal model.
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Our behavioral results show that individuals with MS have impairments in the
precision of the low extremity force production, which is consistent with our previous
work (Davies et al., 2015; Arpin et al., 2016). Specifically, we found that individuals with
MS had slower reaction times and a greater amount of overshoot of the presented
targets. These impairments in behavioral performance may suggest motor planning
deficits. However, no differences were seen in the pre-movement beta ERD, suggesting
that motor planning was intact in these individuals. We propose that this apparent
contradiction could be due to a number of factors. While motor planning may be intact,
the demyelination of the cortical and spinal tracts may cause a delay in the signal from
the cortex to the muscle (Conte et al., 2009). Alternatively, it is possible that the
difference in reaction time is due to increased processing time required by individuals
with MS to perform the appropriate sensorimotor transformations, as these fiber tracts
may be damaged (Bonfiglio et al., 2006; Bonzano et al., 2009). This may be the best
explanation, as there does not appear to be a difference in the latency of the premovement beta ERD, indicating the delayed reaction time is occurring prior to the
formulation and execution of the motor plan. Finally, although the beta ERD appears
similar, the motor plan is likely corrupt since the overshoot is substantially greater,
indicating heightened errors in the motor output. This increase in the amount of
overshoot may also indicate deficits in the ability to properly estimate the amount of
force required to reach the target, further suggesting that the internal model may be
corrupt in individuals with MS.
Lastly, we found correlations between the strength of the PMBR and the time to
successfully match the target, as well as reaction time. These correlations suggest that a
stronger PMBR is partially related to improved performance on the goal-directed knee
force task. Moreover, these correlations imply that the strength of the PMBR is related to
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the certainty of the internal model. Specifically, time to reach the target may indicate the
integrity of the internal model by representing a measure of the ongoing comparisons
that occur between the internal model and the current motor outcome (Kording et al.,
2004; Shadmehr, 2004; Wolpert, 2007). Likewise, we speculate that the reaction time
difference might represent a delay in the sensorimotor transformation, which could
impact the ability to maintain and update the internal model.
Conclusion
Our results show that individuals with MS have impairments in the precision of
the lower extremity force production, as well as reduced cortical oscillatory activity
following movement termination. Since a stronger PMBR is related to improved certainty
of the internal model, we speculate that the internal model is faulty in individuals with
MS. Potentially, the internal model may become corrupt overtime due to the
demyelination in the cortical and spinal tracts that are necessary for relaying sensory
feedback and properly updating the internal model. We suggest that degradation in the
PBMR deserves further attention because it may result in a novel biomarker that can be
used to assess the efficacy of the current treatment protocols that are being used in MS.
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CHAPTER 4: A REDUCED SOMATOSENSORY GATING RESPONSE IN
INDIVIDUALS WITH MULTIPLE SCLEROSIS IS RELATED TO WALKING
IMPAIRMENT
Introduction
Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central
nervous system (CNS) that results in demyelination of the axons in the brain and spinal
cord. This demyelination reduces nerve conduction velocity, impairing the function of the
CNS (White & Dressendorfer, 2004). While the symptoms vary widely between
individuals, many experience mobility and balance impairments that limit their activities
of daily living (Ellis & Motl, 2013). Approximately 50% of individuals with MS will require
the use of a walking aid within 15 years of onset of the disease (Tremlett et al., 2006).
Furthermore, approximately 70% of individuals with MS report gait dysfunction to be the
most challenging aspect of the disease (LaRocca, 2011).
Historically, the clinical impression was that these mobility impairments were due
to weaker muscles that fatigue at a faster rate (Armstrong et al., 1983; Chen et al., 1987;
Ponichtera et al., 1992; Rice et al., 1992; Kent-Braun et al., 1997; Lambert et al., 2001).
Although this is a likely factor, several prior studies have shown that sensory deficits,
particularly loss of tactile sensation, are also related to impaired standing balance and
walking performance in individuals with MS (Thoumie & Mevellec, 2002; Citaker et al.,
2011). Despite this information, our understanding of the link between the sensory and
motor systems is limited, and very few rehabilitation strategies have targeted the
sensory impairments (Cattaneo et al., 2007; Gandolfi et al., 2015). Further interrogation
of the sensory system, and its relation to motor function in individuals with MS, is needed
to improve our understanding of the link between these two systems.
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Sensory gating is a physiological process by which the central nervous system
inhibits or suppresses redundant sensory information. Paired-pulse stimulation, which
results in an attenuated neural response to an identical second stimulation when
presented with a sufficiently short stimulus onset asynchrony, is commonly employed to
assess sensory gating. This gating response is believed to serve as a protective
mechanism, which prevents higher-order cortical centers from being flooded with
unnecessary or redundant information (Boutros & Belger, 1999; Cheng et al., 2016).
Historically, a number of sensory gating investigations have been used to establish that
auditory gating deficits are associated with schizophrenia (Adler et al., 1982; Bramon et
al., 2004; Cromwell et al., 2008). More recently, however, gating deficits have also been
investigated in other neurologic populations (Jessen et al., 2001; Rosburg et al., 2008;
Matsuzaki et al., 2014), as well as elderly individuals (Lenz et al., 2012). Additionally,
despite the gating response occurring during the early stages of perceptual processing,
it has been suggested that aberrant responses impact later cognitive processing and the
formation of memories (Cheng et al., 2016). Moreover, a reduced somatosensory gating
has been shown to be related to decreased tactile discrimination in older adults (Lenz, et
al., 2012). Altogether these results imply that examination of sensory gating could
provide unique information about the integrity of the sensory system.
The purpose of this investigation was to assess the integrity of the sensory
system by quantifying sensory gating in individuals with MS. To this end, we applied
paired-pulse

electrical

stimulation

to

the

posterior

tibial

nerve

while

magnetoencephalography (MEG) was concurrently used to record neural responses.
Additionally, we evaluated the spatiotemporal walking kinematics of these individuals to
explore whether sensory gating may be related to the impaired mobility of individuals
with MS.
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Methods
Participants
Eleven individuals with relapsing-remitting or secondary progressive MS (Age =
56.1 + 6 yrs.; Female = 9) and twelve healthy age and sex matched individuals (Age =
54.7 + 7; Female = 9) participated in this study. The individuals with MS had an average
Kurtzke Expanded Disability Status Scale of 5.5 + 0.8, which indicated that on average
they could walk independently for at least 100 m. At the time of data collection, none of
the patients had had a relapse or a change in medication for at least 3 months. All
testing was done at the University of Nebraska Medical Center. The Institutional Review
Board at the University of Nebraska Medical Center reviewed and approved the protocol
for this investigation. Additionally, all participants provided informed consent prior to
participation in this investigation.
Experimental Paradigm
The participants were seated with their eyes closed in a custom-made
nonmagnetic chair with their head positioned within the MEG helmet-shaped sensor
array. Unilateral electrical stimulation was applied to the right posterior tibial nerve using
external cutaneous stimulators. For each participant, 120 paired-pulse trials were
collected using an inter-stimulus interval of 500 ms and an inter-pair interval that
randomly varied between 4.5 and 4.8 s. Each pulse was comprised of a 0.2 ms
constant-current square wave that was increased in amplitude until there was a subtle
flexion of the first phalange of the foot. Epochs were a total duration of 1.2 s, ranging
from -0.2 to 1.0 s, with 0.0 s representing stimulation onset.
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MEG Data Acquisition and Coregistration
All MEG recordings were conducted in a one-layer magnetically shielded room
with active shielding engaged for advanced environmental noise compensation. During
data acquisition, participants were monitored via real-time audio-video feeds from inside
the shielded room. Neuromagnetic responses were acquired with a bandwidth of 0.1 –
330 Hz and were sampled continuously at 1 kHz using an Elekta Neuromag system
(Helsinki, Finland) with 306 MEG sensors, including 204 planar gradiometers and 102
magnetometers. With the use of the MaxFilter software (Elekta), each MEG dataset was
individually corrected for head motion during task performance and subjected to noise
reduction using the signal space separation method with a temporal extension (Taulu &
Simola, 2006).
Four coils were affixed to the head of the participant and were used for
continuous head localization during the MEG experiment. Before the experiment, the
location of these coils, three fiducial points, and the scalp surface were digitized to
determine their three-dimensional position (Fastrak 3SF0002, Polhemus Navigator
Sciences, Colchester, VT, USA). Once the participant was positioned for MEG
recording, an electric current with a unique frequency label (e.g., 322 Hz) was fed to
each of the four coils. This induced a measurable magnetic field and allowed each coil to
be localized in reference to the sensors throughout the recording session. Since the coil
locations were also known in head coordinates, all MEG measurements could be
transformed into a common coordinate system. With this coordinate system (including
the scalp surface points), each participant’s MEG data was coregistered with structural
T1-weighted MRI data using three external landmarks (i.e., fiducials) and the digitized
scalp surface points prior to source space analyses. Structural MRI data were aligned
parallel to the anterior and posterior commissures and transformed into the Talairach
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coordinate system (Talairach & Tournoux, 1998) using the volumetric subspace warping
method implemented in BrainVoyager QX version 2.2 (Brain Innovations, The
Netherlands).
MEG Processing
Artifact rejection was based on a fixed threshold method, supplemented with
visual inspection. Artifact-free epochs were time-domain averaged with respect to
stimulus onset and then digitally filtered 0.1 to 120 Hz. The peak response to the first
stimulation was evident at the sensor level and occurred approximately 80 ms after
stimulation across all subjects. Thus a 40 ms window, centered over the peak of this
response, was modeled as a regional current source using the subset of sensors that
covered both magnetic flux extrema. The resulting regional sources were all located
within the leg area of the primary somatosensory cortices and had an average goodness
of fit of 0.70 + 0.13. We found the peak source amplitude of the response to the first
stimulation (Peak 1) and the peak source amplitude of the response to the second
stimulation (Peak 2). Using these peak amplitudes, we calculated the gating ratio by
dividing Peak 2 by Peak 1. A gating ratio that is closer to 1 indicates a reduced gating
response. Additionally, we calculated the latency to the peak of each of these
responses.
Mobility Analysis
All participants were instructed to walk across a digital mat (GaitRITE, Sparta,
NJ) at their preferred walking speeds. The mat digitized the locations of the feet, which
were used to quantify the participant’s walking velocity, cadence, step length and step
width. Each participant completed two walking trials and the data from these two trials
was averaged together.
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Statistical Analysis
Shapir-Wilk’s test of normality was used to determine whether the data was
normally distributed. Those data that failed the test were subsequently logarithmically
transformed for all statistical testing. Separate mixed model (Group x Peak Number)
ANOVAs with least-significant difference post hoc were used to examine the differences
between patients with MS and healthy individuals for the latency and amplitude.
Additionally, separate t-tests were used to determine if there were differences in the
spatiotemporal kinematics, as well as the gating ratio, between the two groups.
Spearman rho rank order correlations were subsequently performed between significant
variables. All statistical analyses were performed in SPSS version 23 (IBM, Armonk, NY)
at a 0.05 alpha level.
Results
MEG Analysis
Exemplary regional source time series from an individual with MS and a healthy
individual are shown in Figure 9. Inspection of these time series clearly shows that the
amplitude of the somatosensory response to the second stimulus is extenuated in the
individual with MS compared with the healthy control. This response was typical of what
was seen across all of the participants with MS.
Analysis of the regional source time series revealed no significant group (F(1,21)
= 1.65; p = 0.21) or peak (F(1,21) = 1.13; p = 0.30) main effect for latency, indicating
that there were no differences in latencies between the two groups (MS = 83.41 + 5.29
ms, Controls = 76.29 + 5.06 ms) or between the response to the first and second stimuli
(stimulus 1 = 80.35 + 17.90 ms, stimulus 2 = 79.04 + 17.61 ms).
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Figure 9: Exemplary Paired-Pulse Somatosensory Source Time Series. Exemplary
regional source time series taken from the primary somatosensory cortices for a patient with
MS (top) and a healthy individual (bottom). Stimulus onset is indicated by the red dashed line,
which occurred at times 0.0 s and 0.5 s.

There was a significant group main effect for amplitude (F(1,21) = 8.97; p =
0.007), with patients with MS having greater response amplitudes than healthy
individuals (MS = 20.02 + 2.70 nAm, Controls = 11.09 + 2.58 nAm). There was also a
significant peak main effect for amplitude (F(1,21) = 19.806; p = 0.001), indicating that
the amplitude of Peak 1 was stronger than the amplitude of Peak 2 (Peak 1 = 18.06 +
10.93 nAm, Peak 2 = 12.66 + 9.55 nAm). There also was a significant peak x group
interaction (F(1,21) = 6.32; p =0.02). The post hoc analysis indicated that there was no
significant difference between the two groups for the amplitude of Peak 1 (MS = 21.97 +
13.29 nAm, Controls = 14.46 + 6.99 nAm; p = 0.10). However, the amplitude of Peak 2
was significantly greater in patients with MS compared to healthy controls (Figure 10A; p
= 0.006). There was also no significant difference between the amplitude of Peak 1 and
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Peak 2 for the individuals with MS (p = 0.44). However, the healthy individuals had
significantly reduced Peak 2 amplitudes relative to Peak 1 (Figure 10A; p = 0.02).
Our results also indicated that the individuals with MS had a significantly reduced
somatosensory gating compared to healthy individuals (p = 0.04; Figure 10B). Taken
together, this suggests that while there was not a significant difference in the latencies of
the peak responses, the individuals with MS were not able to properly gate the response
to the second stimulation.

Figure 10: Amplitude and Gating Ratio Results. A) Group averages (mean + SD) for the
amplitude of Peak 1 and Peak 2 (MS = grey, Controls = white), and B) the gating ratios. * p <
0.05.

Mobility Analyses
The spatiotemporal walking kinematics were significantly different between the
two groups for all variables. At preferred walking speeds, individuals with MS had slower
walking velocity (MS = 0.70 + 0.27 m/s, Controls = 1.20 + 0.16 m/s, p<0.01), slower
cadence (MS = 87.20 + 16.44 steps/min, Controls = 107.73 + 8.73 steps/min, p<0.01),
shorter step length (MS = 0.47 + 0.11 m, Controls = 0.67 + 0.07 m, p<0.01), and wider
step width (MS = 0.13 + 0.06 m, Controls = 0.09 + 0.03 m, p<0.01).
There were moderate negative rank order correlations between the amplitude of
Peak 2 and walking velocity (r = -0.52, p<0.01) and step length (r = -0.53, p<0.01).
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These correlations implied that individuals that walked slower and used a shorter step
length tended to have a larger amplitude for Peak 2. Additionally, we found a moderate
positive correlation between the amplitude of Peak 2 and step width (r = 0.47, p=0.01).
This correlation implies that individuals that used a wider step width tended to have a
larger amplitude for Peak 2.
Moderate negative rank order correlations were also found between the gating
ratio and walking velocity (r = -0.37, p = 0.04) and step length (r = -0.39, p = 0.03).
Additionally, we found a moderate positive correlation between the gating ratio and step
width (r = 0.40, p = 0.03). Altogether, these correlations imply that reduced
somatosensory gating may be partially related to the mobility impairments seen
individuals with MS.
Discussion
This study examined the somatosensory gating in individuals with MS using
applied paired-pulse electrical stimulation to the posterior tibial nerve. Our results
demonstrated that individuals with MS showed a decreased somatosensory gating ability
compared to healthy individuals. We also found differences in the spatiotemporal
walking kinematics of individuals with MS compared to healthy individuals, which has
been well documented in the MS literature (Benedetti et al., 1999; Kelleher et al., 2010;
Arpin et al., 2016). Our results extend these observations by suggesting that sensory
gating deficits are partially related to the poor mobility seen in these individuals.
Our results showed no differences in the latency of the amplitude of Peak 1 and
Peak 2 between the two groups. This was unexpected, as it is well known that latent
sensory responses often occur in individuals with MS due to demyelination (Trojaborg &
Petersen, 1979). Potentially, this may be because we selected to use the response with
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the largest amplitude, which occurred around 80 ms, rather than the early ~40 ms
response sometimes reported in the literature (Nakanishi et al., 2014). We elected to use
this later response because it showed the greatest change in amplitude and was the
most reliable response. Furthermore, it has been suggested that somatosensory gating
may be better assessed by later components of the somatosensory response (Thoma et
al., 2007). Alternatively, it is possible that these sensory tracks remain intact and may
not have been subjected to demyelination in the participants used for this experiment.
However, we cannot support this conjecture because we did not have an assessment of
the thalamocortical and spinal tract integrity. Further exploration of the relationship
between the interplay between the integrity of the fiber tracks (i.e., diffusion tensor
imaging) and the latency of the somatosensory cortical response is warranted.
No differences were seen between the two groups for the amplitude of Peak 1;
however, the individuals with MS showed greater Peak 2 amplitudes compared to the
healthy individuals. This difference resulted in reduced somatosensory gating for the
individuals with MS compared to the healthy individuals. Currently, the exact
mechanisms behind sensory gating are not fully understood; however, evidence
suggests

that

gamma-aminobutyric

acid

(GABA)

neurotransmitters

modulate

somatosensory gating (Huttunen et al., 2008). Damage to the inhibitory interneurons and
dysregulation of GABA neurotransmitters have been reported in a histological study of
individuals with progressive MS (Dutta et al., 2006). Therefore, the reduced
somatosensory gating we observed may indicate that the activity of inhibitory
intracortical circuits is altered in individuals with MS. Prior transcranial magnetic
stimulation (TMS) studies appear to support this idea by showing that individuals with
MS have reduced intracortical inhibition (Caramia et al., 2004; Liepert et al., 2005; Conte
et al., 2009; Vucic et al., 2012). Furthermore, this notion is further supported by other
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TMS studies that have identified that the impaired intracortical inhibition is related to
EDSS scores (Conte et al., 2009; Vucic et al., 2012), and is apparent in individuals who
are in the relapsing phase (Caramia et al., 2004).
Negative correlations were found between the amplitude of Peak 2 and walking
velocity, as well as step length. This indicates that the individuals with an aberrant
sensory gating response tended to walk slower and selected a shorter step length.
Additionally, we found a positive correlation between the amplitude of Peak 2 and the
step width, indicating that the individuals with an uncharacteristic sensory gating
response also took wider steps, presumably to increase their base of support. Taken
together, these results may suggest that reduced intracortical inhibition is partially
related to the altered walking performance of individuals with MS. This notion is
supported by prior work that has found that lower GABA concentrations in the
sensorimotor cortex are related to reduced motor performance in individuals with
secondary progressive MS (Cawley et al., 2015). In addition, several other studies have
shown that the sensory deficits, particularly loss of tactile sensation and proprioception,
are related to impaired standing balance and walking performance in individuals with MS
(Thoumie & Mevellec, 2002; Citaker et al., 2011). Together this evidence suggests that
the motor impairments present in individuals with MS are partially related to the neural
computations associated with processing sensory information.
Conclusion
Our results show that individuals with MS have a reduced somatosensory gating
response. This suggests that the inhibitory intracortical circuits may be altered in these
individuals. Additionally, the altered spatiotemporal gait kinematics seen in the
individuals with MS were related to the extent of the somatosensory gating. This
suggests that the motor performance impairments seen in individuals with MS are
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related to sensory processing deficits. We suggest that future investigations and clinical
treatment protocols aimed at improving motor performance in these individuals place
greater attention on improving these sensory processing deficits.
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CHAPTER 5: REDUCED MOVEMENT-RELATED SOMATOSENSORY GATING IN
INDIVIDUALS WITH MULTIPLE SCLEROSIS MAY INDICATE IMPAIRED
SENSORIMOTOR INTEGRATION
Introduction
Multiple sclerosis (MS) is a demyelinating disease that impacts the function of the
central nervous system, and often results in impaired muscular performance. Previously,
we have shown that individuals with MS have greater errors when attempting to control
the precision of the lower extremity force production (Davies et al., 2015; Arpin et al.,
2016). While these results are insightful, the neurophysiological abnormalities that may
be responsible for the reduced muscular force control remain unknown.
It is well established that the integration of sensory and motor information is
essential to the performance of precise movements. However, previous work shows that
individuals with MS often display sensory impairments (Rae-Grant et al., 1999). These
sensory impairments could impact the motor performance of individuals with MS. For
example, several studies have shown that sensory deficits, particularly loss of tactile
sensation, are related to impaired standing balance and walking performance in
individuals with MS (Thoumie & Mevellec, 2002; Citaker et al., 2011). Despite this
information, our understanding of the interaction between the sensory and motor
systems is limited, and few attempts have been made to target sensory impairments in
the current rehabilitation strategies (Cattaneo et al., 2007; Gandolfi et al., 2015). Further
interrogation of the sensory system, and its relation to motor function in individuals with
MS, is needed to improve our understanding of the link between these two systems.
One way of probing the relationship between the sensory and motor systems is
to assess the attenuation of neural responses to somatosensory stimulation during
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movement. Numerous studies have demonstrated that somatosensory input to the
cerebral cortex is attenuated (or gated) during and before voluntary movement, and
during passive movements (Kristeva-Feige et al., 1996; Shimazu et al., 1999; Murase et
al., 2000; Staines et al., 2000; Asanuma et al., 2003; Wasaka et al., 2003, 2005;
Macerollo et al., 2016). Presumably this phenomenon represents how the central
nervous system filters out irrelevant afferent information in order to efficiently process
the most relevant stimuli (Rushton et al., 1981; Cohen & Starr, 1987; Saradjian, 2015).
Additionally, several studies have suggested that movement-related sensory gating may
be useful for investigating sensorimotor integration in healthy and clinical populations
(Kristeva-Feige et al., 1996; Shimazu et al., 1999; Murase et al., 2000; Asanuma et al.,
2003; Nakata et al., 2011).
This sensory attenuation phenomenon can originate from two main mechanisms.
Sensory gating can occur through inhibitory interactions between the given sensory
afferent signals and the afferent feedback from the muscles, joint, and skin caused by
the movement itself. This mechanism is referred to as centripetal gating or peripheral
gating, and can be thought of as a sensory competition between the afferent signals
(Jones et al., 1989; Wasaka et al., 2003; Saradjian, 2015). Alternatively, sensory gating
can occur through interactions between the given sensory afferent signals and the
efferent signals induced by the motor command. This mechanism is referred to as
centrifugal gating or central gating (Jones et al., 1989; Wasaka et al., 2003; Saradjian,
2015). Centripetal gating is thought to occur at the peripheral level as well as in the
spinal cord and brain, while centrifugal gating might occur mainly in the cortex and
subcortical structures (Wasaka et al., 2003). Furthermore, gating that occurs before the
onset of movement must be the result of centrifugal gating, while gating that occurs
during passive movement must be the result of centripetal gating (Jones et al., 1989).
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However, gating during active movement may be due to a combination of both
centrifugal and centripetal gating.
The purpose of this study was to assess movement-related somatosensory
gating in individuals with and without MS. To this end, we applied single-pulse electrical
stimulation to the posterior tibial nerve, both at rest and during movement, while
magnetoencephalography (MEG) was concurrently used to record neural responses.
Additionally, we evaluated the amount of variability or error in the motor output during a
separate ankle control task to assess the motor performance of these individuals. Finally
we explored whether movement-related somatosensory gating was related to motor
performance.
Methods
Participants
Eleven individuals with relapsing-remitting or secondary progressive MS (Age =
57.0 + 7 yrs.; Female = 9) and twelve healthy age and sex matched controls (Age = 54.3
+ 7; Female = 11) participated in this study. The individuals with MS had an average
Kurtzke Expanded Disability Status Scale of 5.4 + 0.8. At the time of data collection
none of the patients had had a relapse or a change in medication for at least 3 months.
All testing was done at the University of Nebraska Medical Center. The Institutional
Review Board at the University of Nebraska Medical Center reviewed and approved the
protocol for this investigation. Additionally, all participants provided informed consent
prior to participation in this investigation.
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Experimental Paradigm
The participants were seated in a custom-made nonmagnetic chair with their
head positioned within the MEG helmet-shaped sensor array. Unilateral electrical
stimulation was applied to the right posterior tibial nerve using external cutaneous
stimulators as the participant sat quietly focused on a fixation cross (passive condition),
or performing an ankle force target matching task (active condition). During both the
passive and active conditions, trials were collected using an inter-pair interval that
randomly varied between 1.8 and 2.2 s. Each pulse was comprised of a 0.2 ms
constant-current square wave that was increased in amplitude until there was a subtle
flexion of the first phalange of the foot. Epochs were a total duration of 0.7 s, ranging
from -0.2 to 0.5 s, with 0.0 s representing stimulation onset.
During the active condition participants were instructed to perform an isometric
ankle plantarflexion target matching task. The participants used their right foot to match
target forces that varied randomly between 5-30% of the participant’s maximum
isometric ankle plantarflexion force. The target force was visually displayed as a box on
a back-projection screen that was ~1 meter in front of the participant at eye level, and
the force generated by the participant was shown as a smaller box (beneath the larger
box) that moved vertically based on the isometric force generated (Figure 11A). Each
participant performed ~240 target matching trials. Each trial lasted 1.5 s and was
followed by a 0.8 s rest period. The speed of the target matching task allowed us to
increase the number of trials during which electrical stimulation occurred during
movement.
A custom-built magnetically-silent force transducer was used to measure the
isometric ankle plantarflexion forces generated by the participants. This device consisted
of a 20 x 10 cm airbladder that was inflated to 317 kPa, and centered below the
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metatarsal phalangeal joints. A custom-made ankle foot orthotic brace held the
airbladder in place and secured it to the foot of the participant (Figure 11B). Changes in
the pressure of the airbag as the participant generated an isometric contraction were
quantified by an air pressure sensor (Phidgets Inc., Calgary, Alberta, CA), and were
subsequently converted into units of force. The force data were sampled at 1 kHz and
were used to identify movement onset in the MEG data.
Prior

to

the

MEG

recording, each participant
performed

an

isometric

ankle joint control task while
seated

within

the

MEG

room, similar to the target
matching task. The task was
designed to measure the
participant’s control of their
ankle joint musculature, and

Figure 11: Depiction of Pneumatic Force Transducer
and Target Matching Task. A) Depiction of the custommade ankle foot orthotic with the custom-built pneumatic
force transducer that was centered below the metatarsal
phalangeal joints of the participant. B) Depiction of the
target matching task. The isometric ankle plantarflexion
force generated by the participant animates the yellow box
to ascend vertically to match the green target box.

consisted of two submaximal steady-state isometric contractions at 20% of their
maximum voluntary force. Each steady-state contraction was performed for 30 seconds.
The coefficient of variation (CV = [Standard Deviation of Force/Mean Force] x 100) was
used to assess the amount of variability present in the middle 15 seconds of the steadystate force. A lower CV value was an indication of greater motor control of the joint
steady-state force (Christou & Tracy, 2006). These two trials were then averaged
together for all data measures.

66
MEG Data Acquisition and Coregistration
All MEG recordings were conducted in a one-layer magnetically shielded room
with active shielding engaged for advanced environmental noise compensation. During
data acquisition, participants were monitored via real-time audio-video feeds from inside
the shielded room. Neuromagnetic responses were acquired with a bandwidth of 0.1 –
330 Hz and were sampled continuously at 1 kHz using an Elekta Neuromag system
(Helsinki, Finland) with 306 MEG sensors, including 204 planar gradiometers and 102
magnetometers. With the use of the MaxFilter software (Elekta), each MEG dataset was
individually corrected for head motion during task performance and subjected to noise
reduction using the signal space separation method with a temporal extension (Taulu &
Simola, 2006).
Four coils were affixed to the head of the participant and were used for
continuous head localization during the MEG experiment. Before the experiment, the
location of these coils, three fiducial points, and the scalp surface were digitized to
determine their three-dimensional position (Fastrak 3SF0002, Polhemus Navigator
Sciences, Colchester, VT, USA). Once the participant was positioned for MEG
recording, an electric current with a unique frequency label (e.g., 322 Hz) was fed to
each of the four coils. This induced a measurable magnetic field and allowed each coil to
be localized in reference to the sensors throughout the recording session. Since the coil
locations were also known in head coordinates, all MEG measurements could be
transformed into a common coordinate system. With this coordinate system (including
the scalp surface points), each participant’s MEG data was coregistered with structural
T1-weighted MRI data using three external landmarks (i.e., fiducials) and the digitized
scalp surface points prior to source space analyses. Structural MRI data were aligned
parallel to the anterior and posterior commissures and transformed into the Talairach
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coordinate system (Talairach & Tournoux, 1998) using the volumetric subspace warping
method implemented in BrainVoyager QX version 2.2 (Brain Innovations, The
Netherlands).
MEG Processing
Artifact rejection was based on a fixed threshold method, supplemented with
visual inspection. Artifact-free epochs were time-domain averaged with respect to
stimulus onset and then digitally filtered 0.1 to 120 Hz. The peak response to the
electrical stimulation occurred approximately 70 ms after stimulation across all subjects,
for both conditions. Thus a 40 ms window, centered over the peak of this response, was
modeled as a regional current source using the subset of sensors that covered both
magnetic flux extrema. The resulting regional sources were all located within the leg
area of the primary somatosensory cortices and had an average goodness of fit of 0.82
+ 0.11. We found the peak source amplitude of the response during both the passive
and active conditions. Additionally, we calculated the latency to the peak of each of
these responses.
Statistical Analysis
Shapir-Wilk’s test of normality was used to determine whether the data was
normally distributed. Those data that failed the test were subsequently logarithmically
transformed for all statistical testing. Separate mixed model (Group x Condition)
ANOVAs with least-significant difference post hoc were used to examine the differences
between patients with MS and healthy individuals for the latency and amplitude.
Additionally, an independent samples t-test was used to determine if there were
differences between the two groups in the CV for the ankle joint control task. Spearman
rho rank order correlations were subsequently performed between the CV and the
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respective sensory response data to assess the relationship between the sensory and
motor systems. All statistical analyses were performed in SPSS version 23 (IBM,
Armonk, NY) at a 0.05 alpha level.
Results
MEG Analysis
Exemplary regional source time series from an individual with MS and a healthy
individual are shown in Figure 12. Inspection of these time series clearly shows that the
amplitude of the somatosensory response during the active condition is extenuated in
the individual with MS compared with the healthy control. This response was typical of
what was seen across all of the participants with MS.

Figure 12: Exemplary Somatosensory Source Time Series. Exemplary regional source
time series taken from the primary somatosensory cortices for a patient with MS and a healthy
individual during the passive (top) and active condition (bottom). Stimulus onset is indicated by
the red dashed line, which occurred at times 0.0 s.

Analysis of the regional source time series revealed no significant group main
effect for latency (F(1,21) = 3.05; p = 0.09). However, we did find a significant condition
main effect for latency (F(1,21) = 8.65; p = 0.008), with the active condition having longer
latencies than the passive condition (Passive = 70.13 + 15.52 ms, Active = 72.65 +
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14.10 ms). There was also a significant condition x group interaction (F(1,21) = 6.26; p =
0.02). The post hoc tests indicated that there was a significant difference in latency
between the two groups during the passive condition (MS = 76.55 + 13.40 ms, Controls
= 64.25 + 15.48 ms; p = 0.05; Figure 13). However, no significant difference in latency
was found between the two groups during the active condition (MS = 76.91 + 12.45 ms,
Controls = 68.75 + 14.91 ms; p = 0.17). Additionally, no significant differences were
found between the active and passive conditions for the individuals with MS (p = 0.94) or
the healthy individuals (p = 0.48).
Additionally,
significant

group

we

found

no

main

effect

for

amplitude (F(1,21) = 0.81; p = 0.38).
However, we did find a significant
condition main effect for amplitude
(F(1,21) = 14.67; p = 0.001), with the
active

condition

having

lower

amplitudes than the passive condition
(Passive = 15.05 + 7.93 nAm, Active =
10.52 + 8.91 nAm). There was also a

Figure
13:
Movement-Related
Somatosensory Peak Latency Results.
Group averages (mean + SD) for the latency of
the peak somatosensory response during the
passive and active conditions (MS = grey,
Controls = white) * p < 0.05.

significant condition x group interaction (F(1,21) = 4.94; p = 0.04). The post hoc tests
indicated that there was no significant difference in amplitude between the two groups
during the passive condition (MS = 15.19 + 9.26 nAm, Controls = 14.91 + 6.90 nAm; p =
0.93), however the difference between the two groups during the active condition was
trending (MS = 14.13 + 11.12 nAm, Controls = 7.22 + 4.63 nAm; p = 0.06). Additionally,
no significant differences were found between the active and passive conditions for the
individuals with MS (p = 0.81), however significant differences were found for the healthy
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individuals (p = 0.004; Figure 14). This suggests that the ability to gate the
somatosensory response during movement was diminished in the individuals with MS.
Ankle Joint Control and Correlation Analyses
No significant difference was found between the two groups for the CV (MS =
2.42 + 1.22, Controls = 2.05 + 1.10, p = 0.23). However, a moderate positive correlation
was found between the CV and the
active amplitude (r = 0.51, p = 0.01). No
significant

correlations

were

found

between the CV and the passive
amplitude, or the latencies (p > 0.05).
This suggests that an inability to gate
the somatosensory response during
movement may be partially related to
the

poor

motor

performance

individuals with MS.

of

Figure
14:
Movement-Related
Somatosensory Peak Amplitude Results.
Group averages (mean + SD) for the amplitude
of the peak somatosensory response during
the passive and active conditions (MS = grey,
Controls = white) * p < 0.05.

Discussion
This study examined movement-related somatosensory gating in individuals with
and without MS using single-pulse electrical stimulation to the posterior tibial nerve, and
the relation of movement-related somatosensory gating to motor performance. Our
results demonstrated sensory gating during movement in the healthy individuals;
however, individuals with MS were unable to properly gate the somatosensory response
during movement. Our results also suggest that the inability to modulate the
somatosensory response during movement is partially related to the poor motor control
seen in individuals with MS.
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Our results showed that the active condition had longer latencies to the peak
amplitude than the passive condition when the groups were combined. Additionally we
found that the individuals with MS had longer latencies to the peak amplitude than the
healthy controls during the passive condition. This is in agreement with prior work
showing increased sensory response latencies in individuals with MS, likely due to
demyelination (Trojaborg & Petersen, 1979). However, no difference in latency to the
peak amplitude was found between the two groups during the active condition. This may
in part be because we selected to use the response with the largest amplitude, which
occurred around 70 ms, rather than the early ~40 ms response sometimes reported in
the literature (Nakanishi et al., 2014). Alternatively, it may be because the sensory
attenuation seen during movement also alters the response latency. The increased
latency in the active condition when combined across groups may support this theory,
however, no differences were seen between the active and passive conditions when the
groups were separated.
No differences were seen in peak amplitude between the active and passive
conditions for the individuals with MS; however, the healthy individuals showed reduced
peak amplitudes during the active condition compared to the passive condition. This
indicates that the individuals with MS were unable to properly gate the sensory response
during movement. Potentially, this could indicate a sensorimotor integration deficit in
individuals with MS (Kristeva-Feige et al., 1996; Shimazu et al., 1999; Murase et al.,
2000; Asanuma et al., 2003; Nakata et al., 2011). In agreement with this, impaired
sensorimotor integration has previously been reported in circuits involving both the
corpus callosum and the brain stem in individuals with MS (Cabib et al., 2015).
Additionally, neuroimaging studies have demonstrated extensive involvement of the
thalamus and basal ganglia in individuals with MS (Calabrese et al., 2010b; Minagar et

72
al., 2013). Furthermore, direct recordings from the thalamus suggest that the thalamus is
involved in movement-related sensory gating (Costa et al., 2008). It has also been
suggested that the basal ganglia is involved in gating sensory influences onto motor
areas of the brain (Menon et al., 1998). Taken together this suggests that the deficits we
have found in movement-related somatosensory gating in individuals with MS could
potentially be a result of damage to the thalamus and basal ganglia. However, MS
results in damage to the entire CNS, making it difficult to identify where the breakdown in
movement-related sensory gating may occur.
An alternative explanation may be that the activity of inhibitory intracortical
circuits is altered in individuals with MS, resulting in failure to properly gate
somatosensory responses during movement. Damage to the inhibitory interneurons and
dysregulation of gamma-aminobutyric acid (GABA) neurotransmitters have previously
been reported in a histological study of individuals with progressive MS (Dutta et al.,
2006). Prior transcranial magnetic stimulation (TMS) studies also appear to support this
idea by showing that individuals with MS have reduced intracortical inhibition (Caramia
et al., 2004; Liepert et al., 2005; Conte et al., 2009; Vucic et al., 2012). Additionally, this
notion is further supported by other TMS studies that have identified that the impaired
intracortical inhibition is related to EDSS scores (Conte et al., 2009; Vucic et al., 2012),
and is apparent in individuals who are in the relapsing phase (Caramia et al., 2004).
In this study we used an isometric contraction during the active condition. In
doing so, we accounted for the fact that somatosensory response amplitudes can be
influenced by the position of the limb (Staines et al., 1996). Additionally, the isometric
task eliminated afferent information due to changes in joint position and muscle length;
however, the cutaneous receptors still provide afferent information related to the amount
of pressure exerted on the force transducer. As a result, we were not able to determine
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whether the individuals with MS displayed deficits specifically in centrifugal or centripetal
gating. We believe it is likely that both centrifugal and centripetal gating are impacted by
the demyelination due to the disease, however, future studies may potentially be able to
investigate this by assessing sensory gating during motor preparation or during passive
movement.
Finally, our results showed no difference between the two groups for the CV
during the ankle control task. This was surprising as we have previously shown
differences in control of the ankle joint musculature between individuals with MS and
healthy individuals (Arpin et al., 2016). We did, however, find a moderate positive
correlation between the CV during the ankle control task and the peak amplitude of the
somatosensory response during the active condition. This indicates that greater
movement-related sensory gating occurs in individuals who have better motor
performance. This is in agreement with previous work, which indicated that greater
gating is related to faster reaction times (Seki & Fetz, 2012) and greater task difficulty
(Rushton et al., 1981). Taken together, this suggests that movement-related sensory
gating is import to motor performance, although the exact nature of this relationship
remains unclear.
Conclusion
Our results show that individuals with MS have a reduced movement-related
somatosensory gating response. Additionally, we found that the control of the ankle joint
musculature was related to the extent of the movement-related somatosensory gating.
These results indicate that movement-related somatosensory gating is impaired in
individuals with MS, and potentially represents impaired sensorimotor integration. We
suggest that future investigations and clinical treatment protocols aimed at improving
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motor performance in these individuals place greater attention on improving these
sensory processing deficits.
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DISCUSSION
Main Outcomes
The main purpose of this dissertation was to assess the behavioral and
neurophysiological deficits present in individuals with MS in order to increase our
understanding of their motor impairments. More specifically, this dissertation used a
combination of behavioral measures and high-density MEG recording to quantify the
motor outcomes and cortical activity of individuals with MS and a group of healthy age
matched controls. The outcomes of this series of studies will provide insight into the
motor control impairments present in individuals with MS, and may be useful in
developing novel treatment strategies designed to improve the motor control of these
individuals.
In the first study, we behaviorally quantified the precision of the steady-state
isometric control of the ankle plantarflexor musculature of individuals with MS, and
evaluated whether the precision of the ankle joint was related to mobility impairment.
Our main hypothesis was that the individuals with MS would have a greater amount of
error in the steady-state isometric ankle plantarflexion task, indicating motor control
impairments. Additionally, we hypothesized that the precision of the ankle plantarflexors
would be related to the spatiotemporal gait kinematics. Our results supported our
hypotheses, indicating that the individuals with MS had a greater amount of variability in
the precision of the isometric ankle torques. Furthermore, this greater amount of
variability in isometric ankle torque was related to decreased walking performance.
These results further fuel the impression that a reduction in control of the ankle joint
musculature may be a key factor in the mobility and balance impairments seen in
individuals with MS. Additionally, we speculated that the increased variability in ankle
plantarflexion performance was due to damage within the CNS which impacted the
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cortical activation associated with planning motor actions (Leocani et al., 2001, 2005).
This hypothesis was the foundation for the second study in this dissertation.
To assess the hypothesis developed based on the results of the first study, the
second study explored the motor planning and execution stages of movement during a
goal directed target matching task performed with the knee joint. Our specific hypothesis
here was that the beta ERD would be reduced both prior to, and at movement onset in
individuals with MS. Interestingly, our results did not support this hypothesis, as no
differences were found between groups in the beta activity during the planning and
execution stages of movement. This appears to suggest that motor planning remains
intact in individuals with MS. However, our behavioral results showed that the final motor
output was faulty. This suggested that the motor plan was likely corrupt, since the
behavioral measures indicated greater errors in motor performance. Additionally, we did
find that individuals with MS had a weaker PMBR in the precentral and postcentral gyri
relative to healthy controls. This finding was of interest because prior work has
suggested that the strength of the PMBR may indicate the certainty of the internal model
(Tan et al., 2016). We also found that the behavioral performance of individuals with MS
was aberrant, and related to the strength of the post-movement beta rebound. Based on
these results, we speculate that the internal model is faulty in individuals with MS.
Potentially, the internal model may become corrupt overtime due to the demyelination in
the cortical and spinal tracts that are necessary for relaying sensory feedback and
properly updating the internal model.
The third study of this dissertation assessed the integrity of the sensory system,
since proper sensory feedback is essential to accurately updating the internal model. To
assess the sensory system we examined the somatosensory gating response using a
paired-pulse tibial nerve stimulation paradigm. Our hypothesis was that individuals with
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MS would display an aberrant somatosensory gating response, which would be related
to their motor performance. Indeed, we found that the amplitude of the response to the
second stimulation was properly reduced in healthy individuals, but not in the individuals
with MS. This resulted in reduced somatosensory gating for the individuals with MS,
suggesting the inhibitory intracortical circuits may be altered in these individuals.
Additionally, we found that the altered spatiotemporal gait kinematics seen in the
individuals with MS were related to the extent of the somatosensory gating. This
suggests that the motor performance impairments seen in individuals with MS are
related to sensory processing deficits.
Building on the results of the previous study, we examined how the sensorimotor
cortex responded to single-pulse tibial nerve stimulation both at rest and during
movement. This provided an indication of how the sensory system was performing
during movement, and how sensory feedback impacts motor control in individuals with
MS. In this final study, we hypothesized that individuals with MS would display aberrant
sensorimotor cortical activity in response to tibial nerve stimulation both at rest and
during movement, and that this aberrant cortical activity would be related to behavioral
measures of motor control. We found no differences in the amplitude of the response
between the two groups during the passive condition. However, we did find a trend
toward a larger amplitude response in the individuals with MS compared to the healthy
individuals during the active condition. We also found that the healthy individuals
displayed the typical reduction in amplitude of the neural response to somatosensory
stimulation during movement, while the individuals with MS were unable to properly
suppress this neural response. Finally, we found that the control of the ankle joint
musculature was related to the extent of the movement-related somatosensory gating.
These results indicated that movement-related somatosensory gating is impaired in
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individuals with MS, and potentially represents impaired sensorimotor integration. All
together, the results of this dissertation provide evidence that the impaired motor control
of individuals with MS may be due to a faulty internal model, which has become corrupt
due to demyelination, and cannot be properly updated due to impaired sensory
processing.
Limitations
There were several limitations to the experiments conducted in this dissertation.
First, each of these investigations was limited by a small sample size. The small sample
sizes make it difficult to know whether these results can be extrapolated to characterize
MS in general, or are simply representative of the individuals who participated in these
experiments. Additionally, it should be noted that the individuals with MS who
participated in these studies were classified as having either relapsing-remitting or
secondary progressive MS. Due to the small sample sizes we were unable to focus on
one specific type of MS, and are therefore unable to comment on how our results may
differ based on type of MS.
Another limitation was that these studies all used isometric target matching tasks
to assess muscular control, however, the isometric tasks used in these studies likely do
not approximate the ankle or knee control required during gait. These tasks were used,
in part, because of the limitations inherent in brain imaging. However, using a more
dynamic force matching task may have also been possible, and may have provided a
better approximation of the muscular control required during gait. Future investigations
with larger sample sizes should confirm the results of these studies, and explore whether
differences exist among the types of MS. Furthermore, experimental methods that
include more dynamic force matching tasks should be explored, as these may provide a
closer approximation of the muscular control required during gait.
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Future Direction
The results of this work supports the theory that the PMBR is related to improved
certainty of the internal model, and suggests that the internal model is faulty in
individuals with MS. Therefore, future studies should further investigate degradation in
the PBMR, as it may result in a novel biomarker that can be used to assess the efficacy
of the current treatment protocols that are being used in MS. Additionally, the results of
the two studies that assessed the neural responses to somatosensory stimulation
indicated that individuals with MS have sensory processing deficits. However, few
attempts have been made to target sensory impairments in the current rehabilitation
strategies (Cattaneo et al., 2007; Gandolfi et al., 2015). Therefore, further investigations
of the efficacy of rehabilitation strategies targeting sensory impairments in comparison to
standard rehabilitation strategies are needed. These types of studies have attempted to
improve sensory deficits through exercises that challenge the deficient sensory system,
such as balance training with the eyes closed to challenge the vestibular and
proprioceptive systems, or balance training on unstable surfaces to challenge the visual
and vestibular systems. Future studies should also aim to develop novel methods of
targeting the sensory systems, such as through biofeedback devices, in order to find
optimal methods of improving these sensory deficits.
Conclusion
This dissertation explored the behavioral and neurophysiological deficits present
in individuals with MS in order to increase our understanding of their motor impairments.
The results of these studies added to the body of literature identifying impairments in the
gait, and lower extremity muscular control, of individuals with MS. More importantly, this
work provides new insight into these motor control deficits, suggesting they may be the
result of a corrupt internal model. Furthermore, these results suggest that these
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impairments may arise from sensory processing deficits, which prevent individuals with
MS from properly updating their internal model. These outcomes provide new insight into
the motor control impairments present in individuals with MS, and may be useful in
developing novel treatment strategies designed to improve the motor control of these
individuals.
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